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ABSTRACT 
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Biomonitoring of Chemical Warfare Agent Exposure 
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Paper spray is an ambient ionization technique for mass spectrometry that is well-
known for its ability to accomplish rapid and sensitive analyses without any need for 
sample preparation. This work further develops the technique in two major areas: negative 
ionization and drug screening. Negative ionization has always been an obstacle to 
electrospray-based ion sources because of its vulnerability to corona discharge, but 
methods are presented here to both quantify and suppress this electrical phenomenon, thus 
preventing it from interfering with qualitative/quantitative analyses. The validity of the 
discharge-suppressing method is demonstrated for both a simple screen of barbiturates and 
other acidic drugs (Chapter 2) and the detection and quantitation of chemical warfare agent 
hydrolysis products (Chapter 3). Additionally, a positive ion drug screen is applied to the 
analysis of postmortem blood samples (Chapter 4), achieving rapid and effective screening 
of 137 different drugs ranging from pharmaceuticals to drugs of abuse. The performance 
of this screen is also evaluated by comparing the results of the postmortem samples to those 
obtained using a more established series of assays. The research contained herein presents 
strides toward forensic application of paper spray mass spectrometry, especially in 
disciplines related to forensic toxicology.
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CHAPTER 1. INTRODUCTION 
Introduction to Paper Spray Mass Spectrometry (PS-MS) 
 For many forensic laboratories, mass spectrometry (MS) serves as the gold standard 
for identification of unknown chemical samples. The ability to detect analytes by mass as 
well as filter them for subsequent fragmentation to monitor the resulting masses—a 
technique referred to as tandem MS, or MS/MS—lends to the impressive selectivity put 
forth by the method. However, up until the 1980s, MS could only viably be paired with the 
separating capabilities of gas chromatography (GC) systems, primarily because of the need 
for ions to be in the gas phase and under vacuum pressures for accurate mass analysis.1 
While GC-MS still remains one of the go-to techniques for volatile samples, the eventual 
development of electrospray ionization (ESI) established the bridge to allow effective and 
direct coupling of liquid chromatography (LC) systems with MS in open air.2-4 This in turn 
provided a simpler means for the previously difficult mass analysis of nonvolatile samples, 
further enabling the implementation of MS as an analytical technique. 
 Even with the ability to connect the two chromatographic systems to MS, though, 
proper analysis still requires a relatively large amount of sample preparation both before 
and including the separation. Such preparatory requirements can be both time-consuming 
and costly, which are non-negligible obstacles when trying to streamline sample 
processing. To address the limitations imposed by chromatography, techniques have been 
developed within the past couple decades that allow for direct ionization of samples within 
their ambient environments (e.g., in blood or on metal surfaces) under atmospheric pressure 
before introduction to the vacuum for MS analysis. Desorption electrospray ionization 
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(DESI)5 and direct analysis in real time (DART)6 were the pioneering ambient ionization 
techniques developed to this extent, with many more to follow.7 
 Notable among the growing list of ambient ionization techniques is paper spray 
(PS). PS was first explored conceptually by Tepper and Kessick using porous polymer 
wicks in 20098 and then with more application in following years, chiefly out of Cooks’ 
and Ouyang’s laboratories at Purdue University.9-14 Operationally, PS functions in the same 
manner as ESI, where a high voltage—usually between 2-5 kV—is applied to a liquid on 
a point to get it to spray toward the MS inlet as shown in Figure 1. The only difference is 
that instead of eluent from a chromatography column flowing through a narrow needle to 
generate the electrospray, the sample is first transferred onto a pointed porous substrate 
and allowed to dry before a spray solvent—equivalent to the mobile phase in LC—is 
applied. The spray solvent wicks through the entirety of the substrate and the dried sample, 
extracting the analytes and conveying them to the tip; an elevated electric field exists 
around the tip of the substrate due to its small radius, which expels charged droplets in the 
form of electrospray toward the MS inlet. Once these droplets are airborne, remaining 
solvent molecules quickly evaporate and successive Coulombic fissions, arising from the 
repulsive forces felt by many charged molecules occupying the same droplet volume, 
generate gas-phase ions that are then drawn into the vacuum of the mass spectrometer. 
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Figure 1. Operation of (a) LC-ESI-MS and (b) PS-MS. 
 By name alone, PS implies ionization from a paper substrate, but this is not 
necessarily true. The term “paper” itself can be associated with many different types of 
materials, all of which may in fact spray very differently. The physical and chemical 
differences between filter paper and chromatography paper, for instance, causes them to 
spray with different efficiencies.9 In general, though, any porous material which allows for 
quick solvent travel through or on it can be used as a spray substrate. To this extent, carbon-
nanotube-coated filter paper,15 polymer-blend fibers,8 porous polymer pen nibs,16,17 
wooden toothpicks,16-18 and even intact plant material such as leaves19 have been 
successfully tested as PS substrates. 
 The conventional and clinically-minded method of transferring samples onto the 
substrate is via direct pipetting, or spotting. Other sampling methods involve wiping the 
substrate on or dipping it into samples, which permits the PS-MS analysis of a much 
broader range of samples9,18,20,21 and demonstrates the ease of applying the technique to 
forensic science and the types of evidence typically encountered at crime scenes. In terms 
of spray solvents, an organic solvent is usually employed with a small amount of aqueous 
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phase to increase the surface tension. To this is added a modifier such as acetic acid or 
formic acid that assists in ionizing the analytes. While chromatography paper substrates 
are versatile and function well for most applications, proper choice of the substrate-solvent 
system in PS is often crucial in optimizing the analytical method. 
 The utilization of PS-MS confers many advantages to the sampling and analytical 
processes. Among these advantages are: ease of patient-end sampling due to the small 
sample volumes required; biological samples spotted and dried on paper, such as dried 
blood spots (DBSs), present a reduced biohazard in storage/transport compared to 
traditional liquid samples; little-to-no sample preparation; reduced matrix effects from the 
rudimentary separation that takes place on the substrate; speedy data acquisition and 
analysis; and cost-effective materials for high throughput. Good quantitation of analytes 
can also be achieved through the use of stable isotope labeled (SIL) internal standards 
(ISTDs). And while adding ISTD to a sample may indicate a small amount of required 
sample preparation, studies have demonstrated the successful quantitation of analytes by 
either pre-treating the substrate with ISTD or including it in the spray solvent, avoiding 
any need to alter the sample.10,11 All of these factors have aided the implementation of PS-
MS in miniature and field-forward MS systems designed for use outside of laboratory 
environments.22,23 
 The breadth of PS-MS applications is wide and constantly growing. The technique 
has proven effective for the quantitative analysis of small molecules such as drugs in 
biofluids, which could be highly beneficial in clinical settings as it is capable of providing 
a rapid means for therapeutic drug monitoring of individuals.10,11,24-26 PS-MS has been 
successfully demonstrated for dye analysis, even after quick chromatographic separation 
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from an ink sample.12,18,27 It has also been used for the detection of contaminants on 
foodstuffs28 and, due to the small sample sizes needed, coupled with microfluidic chips to 
detect products of microchemical reactions.29 Biochemical species of interest such as 
proteins,9,12,17,18 nucleic acids,17 and phospholipids12 have all been investigated using PS-
MS, and it has even been used for the direct analysis of tissue samples.13 The application 
of PS-MS to neonatal screening—specifically through the detection of acylcarnitines, 
which are used in monitoring metabolic deficiencies—has also been demonstrated.30 
Additionally, such already-established applications can be translated to their corresponding 
forensic science disciplines. For example, ink- and drug-based analyses could be relevant 
for purposes of questioned document examination31,32 and forensic toxicology. 
Project Overview 
 The research presented in this thesis further develops PS-MS in two areas: negative 
ionization and drug screening of blood samples. Chapter 2 addresses the plaguing issue of 
corona discharge encountered in negative mode ESI techniques and investigates means to 
suppress it such that sensitive and reliable detection can be accomplished. Also 
demonstrated in Chapter 2 is the application of the developed negative ion PS-MS method 
to a toxicological screen of 19 acidic drugs, with barbiturates and ethanol metabolites 
included among them; a few drugs capable of positive ionization were also analyzed in this 
screen to see how well they could be detected in negative ion mode. Chapter 3 investigates 
the detection and quantitation of chemical warfare agent hydrolysis products in biomatrices 
using PS-MS in both polarities of ionization. Chapter 4 sees the adaptation of a PS-based 
drug screen for 137 analytes33,34 to postmortem samples, which, when developed further, 
would be an invaluable tool for forensic toxicology.
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CHAPTER 2. DEVELOPING PS-MS IN NEGATIVE ION MODE 
Introduction 
 Despite the significant developments that PS has seen over the past decade to 
increase the scope of its applicability, much of this development has only covered positive 
ionization. Few studies have implemented negative ion PS in the detection of analytes, and 
fewer still have discussed the reason behind this relative lack of research.9,12,13,16,18,35 This 
reason is an issue facing not only PS but negative ESI in general: corona discharge.35 
Corona discharge is a glowing electrical event caused by rapid ionization of gas molecules 
which, when applied to ESI systems, overwhelms stable electrosprays. Accompanied by a 
drastic increase in spray current, the appearance of this discharge is known for leading to 
poor reproducibility and sensitivity of the electrospray technique,36 hence why forays into 
PS in the negative ion mode are often brief and underdeveloped compared to those into 
positive ion mode. 
 To demonstrate why the occurrence of corona discharge is detrimental to the 
fundamental ESI process, it is important to discuss the electrical nature of the circuit 
created and how the discharge manifests itself. Figure 2a shows the electrical circuit 
created in negative ion PS, with the high voltage source flipped compared to that of positive 
ionization to apply a negative potential to the paper tip. The high-field region that is 
responsible for propelling negative ions toward the distant and positively charged MS inlet 
is represented by the dashed circle. Ions that scatter around the inlet rather than pass 
through are neutralized via oxidation, establishing the flow of electrons (e-) opposite the 
current (I). Since electron current flows in this direction, individual electrons are readily 
7 
released by the elevated electric field around the negative cathode in a process known as 
field emission.37,38 These free electrons quickly accelerate and collide with gas molecules 
in the region, leading to either electrochemical reduction of gas molecules along with 
subsequent ion-molecule reactions39 or electron avalanches.38,40 
 
Figure 2. (a) The PS-MS negative ion circuit. Electron current (e-) naturally flows to the tip, which emits 
electrons due to the high electric field around it. (b) The chain reaction of electron-releasing ionizations that 
propagates the avalanche, each arrow split indicating an ionization event. (c) A primary electron avalanche 
releasing photons, the circled charges representative of approximate space charge distributions. The 
electrospray gap is very large compared to the high-field region, so the electric field around the distant 
anode has no influence over the propagation of avalanches. 
 Electron avalanches are the primary cause for discharging and electrical 
breakdowns. They occur when an accelerated electron, still within the high-field region, 
has enough energy to completely ionize a molecule, liberating an electron and re-
accelerating to ionizing speeds. This process leads to a chain reaction of electron-induced 
ionizations, producing a swarm of electrons trailed by the slower-moving ionized 
molecules—the avalanche, shown in Figures 2b and 2c—and releasing the photons 
perceived as the glow in corona discharge; the emitted electrons can also trigger secondary 
avalanches that propagate around the primary avalanche.38,40 As long as the electric field 
remains high enough in the vicinity of an avalanche, this propagation can continue 
indefinitely until it bridges the gap to the opposing electrode, leading to a complete spark 
breakdown of the gap.40 
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 However, when considering an ESI source charged with a negative potential such 
as the tip in PS-MS shown in Figure 2, the avalanching develops away from and beyond 
the high-field region. Any further propagation is quenched because the lower field strength 
is insufficient to accelerate electrons to ionizing speeds, preventing formation of full 
breakdown streamers and limiting discharge to the visible corona around the cathode. 
Alternatively, when operating positive ESI, any avalanching develops toward the 
positively charged anode that is the source and into the high-field region; because of this, 
every primary avalanche is guaranteed to fully propagate to the anode, forming partial 
streamers that visually extend outward from the source, leading to the conclusion that 
partial breakdown of the gap occurs at lower voltages for positive ion mode than it does 
for negative ion mode.38,40,41 
 While seemingly conflicting with the notion that corona discharge is more of a 
problem in negative ion mode, this only notes the small voltage difference between corona 
discharge in positive ion mode and the onset of breakdown streamers. In actuality, the onset 
of corona discharge itself occurs at higher voltages in positive ionization due to the higher 
energies needed to ionize gases and generate the free electrons that begin the avalanching 
process in the first place.37,38 Since free electrons are readily released via field emission in 
negative ionization, though, it does not require the higher energies or voltages that positive 
ion mode needs. In fact, because of the nature of the electrical circuit created, there is a 
very small and unreliably defined range of operating voltages in which negative ESI can 
be achieved normally and without discharge. 
 Corona discharge affects sensitivity primarily through its overproduction of ions. 
Those generated from gaseous ion-molecule reactions—O3-, CO3-, CO4-, and NO3-, to name 
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a few39—are all of small mass. As such, they travel faster than most analytes and reach the 
inlet more quickly than their larger counterparts. And in instruments such as ion traps that 
are limited by the number of ions that can be introduced into the system, the increased 
presence of small ions restricts the number of heavier ions that are available for mass 
analysis. Furthermore, when compounded with the overabundance of electrons from the 
unending cascade of avalanches, these ions increase the charge density in the inlet-bound 
ion beam, which causes the noticeable rise in spray current. This increase also enhances 
the space charge effect, which is responsible for defocusing the ion beam and deflecting 
heavier and slower-moving ions by Coulombic repulsion.42 Discharge can also affect 
sensitivity by preventing the Taylor cone from forming at all and therefore inhibiting the 
fundamental electrospray process. When taken together with the fact that negative ion 
mode is naturally prone to discharge, this sensitivity loss is the motivating factor behind 
the lack of negative ESI development, especially for the relatively new PS-MS. 
 Among the primary experimental parameters that influence the susceptibility of the 
tip to discharge are the electrospray gap length (the tip-to-inlet distance in PS-MS) and the 
applied voltage, which directly affect the strength of the electric field at the cathode. When 
ionizing with PS, the presence of stray fibers or burring at paper tip also increases the 
propensity for discharge due to the high electric field at these protuberances. There have 
been studies, however, that address problems with discharge and show successful ESI in 
negative ion mode by incorporating new or different elements into the experimental setup. 
For example, introducing electron-scavenging gases such as SF6
36,43 or O2
44 into the 
electrospray gap has been shown to suppress discharge. Using chlorinated solvents as a 
mobile phase effectively increases the voltage required for the onset of corona discharge 
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without affecting the voltage required for proper Taylor cone formation.2,45,46 Strong 
resistors—on the order of GΩ—positioned between the high voltage source and the ESI 
needle have also demonstrated discharge-suppressing abilities.47-49 And in PS specifically, 
the utilization of alternative substrates such as polyethylene or polyester has shown 
acceptable detection in negative ion mode.16 
 The goal of this study was to investigate the issue of corona discharge in negative 
ion PS-MS and its various remedies as they might be applicable to field-forward PS 
instrumentation. This involved optimization of the experimental setup such that discharge 
could be quantified and reproducibly avoided between samples, preventing it from 
interfering with quantitative analyses. The optimized negative ion method is ultimately 
demonstrated through its use in a drug screen targeting barbiturates—which, while not as 
prevalent or abused today as they have been in the past, still see therapeutic use50—as well 
as several other acidic analytes. 
Materials and Methods 
Chemical Materials 
 High-performance liquid chromatography (HPLC) grade methanol, Optima grade 
ammonium hydroxide (NH4OH), and glacial acetic acid were purchased from Fisher 
Scientific (Pittsburgh, PA, USA). Anhydrous carbon tetrachloride was purchased from 
Sigma Aldrich (St. Louis, MO, USA). Most standards—ibuprofen, naproxen, 
levetiracetam, tadalafil, furosemide, hydrochlorothiazide, warfarin, phenytoin, 
amobarbital, butabarbital, butalbital, pentobarbital, phenobarbital, phenobarbital-d5, and 
ethyl-beta-D-glucuronide—were purchased from Cerilliant (Round Rock, TX, USA) at 
concentrations of either 1.0 mg/mL or 100 μg/mL in methanol. Secobarbital and thiopental 
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were purchased from Sigma Aldrich as 1.0 mg/mL standards. Salicylic acid, valproic acid, 
and sodium ethyl sulfate powders were also purchased from Sigma Aldrich and were 
dissolved in water to generate stock solutions. Ibufenac powder was purchased from Sigma 
and dissolved in dimethyl sulfoxide (DMSO) to create a stock solution. 
 Since the majority of this chapter is dedicated to the development of an optimized 
method, many different samples were made to test different parameters. As such, these 
samples were prepared as described in the Results and Discussion section. For biological 
samples, human whole blood was provided by a single donor and bovine plasma was 
purchased from Lampire Biological Laboratories (Pipersville, PA, USA). All solvent 
mixtures, unless otherwise indicated, were mixed by volume (v:v). 
Paper Spray Ionization 
 PS was accomplished using both manual cartridges and the Velox Sample 
Cartridges (VSCs) designed for use with the automated Velox 360 PS source (Prosolia, 
Indianapolis, IN, USA). The former type of cartridge, shown in Figure 3a, was made by 
using a Sherline milling machine (Vista, CA, USA) to create the holes and slot in a bar of 
Delrin plastic (Quadrant, Fort Wayne, IN, USA). For all experiments, cellulose-based 
Whatman 31ET CHR chromatography paper (Piscataway, NJ, USA) was used as the 
substrate for the punch, onto which 3.5 μL of sample were deposited before drying at room 
temperature. Various substrates were tested as the PS tip, including: Whatman 
chromatography paper; porous polyethylene with assorted pore sizes of 7-12 μm, 15-45 
μm, and 15-50 μm (Porex, Fairburn, GA, USA); and high-density polyethylene (Pore 
Technology, Marietta, TX, USA). These substrates were all cut into the irregular pentagons 
shown and inserted into the cartridge for spraying, positioned ~4-5 mm in front of the MS 
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inlet. Before the voltage was turned on, 40-60 μL of spray solvent was applied into the well 
on top of the sample-spotted paper punch. A Pulnix TM-200 camera (Jai, San Jose, CA, 
USA) with a Navitar Precise Eye adapter tube and lens (Rochester, NY, USA) was used in 
visualizing the PS process for all cartridges sprayed manually. 
 
Figure 3. (a) Manual cartridges and (b) Velox Sample Cartridges (VSCs) used for PS-MS, as well as the 
spotting method for the former. 
 When using the VSCs (Figure 3b), 12 μL of sample were spotted onto the paper tip 
through the sample window and allowed to dry at room temperature. The Velox 360 source 
uses two pumps to apply solvent to the paper tip: pump A, which dispenses in 3-μL 
increments, for application straight onto the dried sample spot, and pump B, which 
dispenses in 10-μL increments, for application into the solvent well. When the VSCs were 
sprayed with this automated PS source, 142 μL of solvent were applied to the cartridge—
12 μL from pump A and 130 μL from pump B. Most often, a large delay was incorporated 
only before the first dispensation of solvent onto the sample, all subsequent delays 
occurring in a quick succession of 2-second intervals. Whenever it was used for automated 
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PS-MS, the Velox 360 source was locked into place against the rim of its mounting flange, 
allowing for no user-end control over the tip-to-inlet distance to keep it consistent between 
sampling across multiple days. VSCs were also occasionally sprayed manually using a 
specially milled bar of Delrin plastic to simply hold them in place in front of the MS inlet—
in these cases, the solvent was applied in such a way as to mimic the dual action of the 
pumps, using it to first wet the sample spot and then dispensing it into the solvent well. 
 To test the discharge-suppressing capabilities of including a resistor in the high 
voltage line, a 10-GΩ-equivalent resistor was created by soldering together ten 1-GΩ 
Ohmite (Warrenville, IL, USA) resistors in series. This large resistor was then connected 
in series between the high voltage source of the mass spectrometer and the PS cartridge. 
When using this resistor as such, cartridges were only ever run manually without the aid 
of the Velox 360 PS source. 
Mass Spectrometry 
 All data were acquired in negative ionization mode using either an LTQ-XL linear 
ion trap mass spectrometer or a Q-Exactive Focus orbitrap mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA, USA). When optimizing the method, both full-MS and 
MS/MS scans were utilized, fragmenting all analytes via collision-induced dissociation 
(CID) at the collision energies (CEs) given in Table 1, which were determined via direct 
infusion ESI of analyte solutions. Onset voltages were typically within the 3.0-4.0 kV 
range—or up to 8.0 kV when using the resistor—with method lengths between 1.0 and 1.4 
minutes. All data were analyzed using Xcalibur v. 4.0 (Thermo Fisher Scientific) and, 
unless otherwise noted, defined signal as the area-under-curve (AUC) response for any 
given precursor or fragment ion. 
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Data Visualization 
 Two types of graphs were employed to visualize the data acquired. Bar graphs were 
used to compare average signals—taken from three to five individual measurements—
across different variables, with the error bars indicating the magnitude of one standard 
deviation above and below these values. To visualize measurement distribution and 
precision of the compared methods, box-and-whisker plots were used. The median of a set 
of measurements was used as the central tendency of such plots, with the box encasing the 
interquartile range between the 25th and 75th percentiles; the whiskers extended outward to 
encompass the 0th and 100th percentiles. 
Negative Ion Drug Screen 
 Several acidic analytes were tested, all of which are given in Table 1 along with 
their precursor and MS/MS fragment ions. Due to the limitations of MS in not being able 
to differentiate structural isomers such as amobarbital and pentobarbital, this initial drug 
screen was separated into two methods to deal with the quantitation of each separately. 
Phenobarbital-d5, a SIL ISTD of phenobarbital, was used in quantitating all barbiturates 
and related structural analogs (amobarbital, butabarbital, butalbital, pentobarbital, 
phenobarbital, secobarbital, thiopental, and phenytoin); ibufenac, a structural analog for 
ibuprofen containing a –COOH moiety, was used as a catch-all ISTD for the remaining 
analytes. 
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Table 1. Fragmentation of the analytes and ISTDs used in the negative ion drug screen. 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
Screening 
Cutoff [ng/mL] 
Butabarbital 211.1088 168.1029 11 500 
Butalbital 223.1088 180.1030 10 500 
Amobarbital 225.1245 182.1185 11 500 
Pentobarbital 225.1245 182.1185 11 500 
Phenobarbital 231.0775 188.0718 10 1000 
Secobarbital 237.1245 194.1187 10 500 
Thiopental 241.1017 100.9812 14 2000 
Phenytoin 251.0824 102.0345 22 1000 
Salicylic acid 137.0244 93.0342 16 9000 
Valproic acid 143.1077 143.1077 10 5000 
Levetiracetam 169.0983 84.0450 10 2000 
Ibuprofen 205.1233 159.1179 10 1000 
Naproxen 229.0869 158.0374 15 1000 
Hydrochlorothiazide 295.9571 268.9460 20 100 
Warfarin 307.0974 161.0245 21 500 
Furosemide 329.0004 285.0103 14 1000 
Tadalafil 388.1307 262.0871 19 100 
Ethyl sulfate 124.9914 96.9598 17 100 
Ethyl-beta-D-glucuronide 221.0668 75.0082 15 100 
Ibufenac 191.1079 107.0500 10 --- 
Phenobarbital-d5 236.1090 193.1032 10 --- 
 
 The analytes were spiked into blood to generate samples at 15× their respective 
screening cutoff concentrations, which were then serially diluted in blood to generate a 5-
point calibration series of 1×, 3×, 6×, 10×, and 15×. 5 μL of an ISTD mixture of 
phenobarbital-d5 and ibufenac were then spiked into 100 μL of each sample to generate 
ISTD concentrations of 0.4 μg/mL and 5.3 μg/mL, respectively. These blood samples were 
spotted in triplicate on VSCs and sprayed from the Velox 360 PS source using 142 μL of 
90:10:0.01 methanol:CCl4:NH4OH. 
 All samples were acquired on the Q-Exactive Focus mass spectrometer using 
MS/MS scans for each analyte and a temperature of 320°C; the isolation width of each 
precursor ion by the first quadrupole was ±0.5 m/z. The method was 1.4 minutes long, with 
the voltage on at 4.0 kV for the first 1.1 minutes and then off at 0 kV for the final 0.3 
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minutes. This no-voltage time was included to allow for automated data analysis using 
TraceFinder v. 3.3 (Thermo Fisher Scientific), which integrated m/z signals within a 5-
ppm window of the target fragment ion. Concentrations were plotted against the measured 
analyte/ISTD signal and lines of best fit were determined using 1/x weighting; LODs were 
calculated with a k-factor of 3 multiplied by the standard error of the y-intercept and 
divided by the slope of the calibration curve. 
Results and Discussion 
Demonstrating the Discharge Problem 
 An example of a PS-MS sample discharging is shown in Figure 4. In this case, the 
analyte—10 μg/mL ibuprofen—was included in the spray solvent, which was a 95:5:0.01 
methanol:water:NH4OH mixture. NH4OH was used as a solvent modifier to facilitate 
negative ion production, the hydroxide ions deprotonating the ibuprofen molecules to form 
[M-H]- molecular ions at m/z 205. The voltage was turned on to 4.0 kV for the middle 0.8 
minutes of the acquisition to allow the sample to spray. In an ideal sample, the total ion 
current (TIC) would remain relatively constant over this window, producing a box-like 
shape from the voltage being switched on and off. During the first half of this acquisition, 
however, light discharge was already occurring, producing spray currents between 1 and 2 
μA along with an unstable TIC; halfway through, the discharge intensified to currents 
around 20 μA, halving the full-MS signal and decreasing the measured ibuprofen precursor 
ion signal by a factor of 40. This loss of signal is readily apparent in the difference between 
the instrumental response for m/z 205 in the mass spectra shown in Figures 4c and 4d. The 
decreased presence of the precursor ion in turn adversely affected the capability of the 
method to adequately perform MS/MS via fragmentation of ions at m/z 205, the resulting 
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MS/MS spectra seeing a 110-fold decrease in the measured fragment ion (m/z 161) signal. 
This significant drop in sensitivity is demonstrated in the MS/MS TIC plot seen in Figure 
4b, where almost all signal virtually vanishes with the onset of heavy discharge. 
 
Figure 4. (a) Full-MS and (b) MS/MS of m/z 205 TIC plots of a single discharging PS-MS sample. Inset in 
(a) is a camera-aided visualization of corona discharge on paper tips. At 0.44 min, the discharge intensified 
to more noticeable levels, (c) and (d) showing the full mass spectra before and after this point, respectively. 
In the mass spectra, m/z 205 is ibuprofen’s precursor ion, m/z 60 is CO3-, and m/z 62 is NO3-. 
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 Depending on the strength of any occurring discharge across multiple samples (e.g., 
the difference between 2 μA and 20 μA), such decreases in sensitivity can take a toll on 
reproducibility of single-concentration measurements, driving up standard deviations and, 
when generating calibration curves, impairing limits of detection (LODs) and quantitation 
(LOQs). Theoretically, the use of ISTDs when attempting to quantitate should prevent any 
occurrence of discharge from significantly affecting analyses. But when different masses 
exhibit different extents of sensitivity loss by nature of the discharge itself and the effects 
of space charge, measuring analyte/ISTD responses produces values that significantly 
disagree with those of non-discharging samples, further harming any attempted 
quantitation. 
 Aside from the dramatic decrease in analyte sensitivity apparent in Figure 4d, it is 
also important to observe the overwhelming presence of m/z 60 and 62. These masses 
respectively correspond to CO3
- and NO3
-, two ions which are produced in negative 
corona.39 Expressed as a percentage of the full-MS TIC, they comprised 12.81% and 
14.67% of all signal during the period of heavy discharge (~20 μA) seen over the last half 
of the acquisition. To a lesser extent, m/z 60 and 62 can even be seen in Figure 4c, where 
the weaker discharge (1-2 μA) was occurring, although they only comprised 0.44% and 
1.15% of the TIC in this section. It thus follows that tracking these two specific ions in 
full-MS can serve as an indicator of corona discharge, providing an easily measurable 
means to monitor differences in discharge between samples. This tracking of ions with 
relation to discharge is not novel; previous experiments have utilized the discharge-driven 
production of ions—specifically CH3OH2+—for similar diagnostic purposes.36,51 While 
any such applications have only been performed for positive ion ESI, the tracking of CO3
- 
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and NO3
- in negative ion mode effectively served to indicate and quantify discharge where 
and when it occurred. Combined with the frequency of occurring discharge in a given 
sample set, this removed the need to visually observe samples as they spray, which was 
crucial when moving toward the high-throughput and automated PS-MS methods that are 
ideal for drug screens. 
 However, this ability to quantify and track corona discharge is not without its 
limitations. First, abrupt changes in signal due to a disruption in the normal spraying 
process—such as what might be seen when the Taylor cone collapses mid-acquisition or 
when the spray is generally unstable—can cause the measured m/z 60 and 62 signals in 
full-MS to artificially increase, even in the absence of the complementary increase in spray 
current that would definitively indicate discharge. Whereas the measurements that were 
performed on the mass spectra in Figure 4 were taken from each section individually, all 
other such discharge measurements presented here were taken across the entirety of a single 
acquisition; if the signal was not relatively constant throughout the acquisition, the 
discharge measurements rose and led to false positives. If necessary, such samples could 
be processed individually, but in terms of PS-MS method optimization, having information 
about spray stability—even if masked as potential discharge—was also useful, as samples 
should spray consistently between multiple trials and achieve a constant spray strength over 
the entire acquisition. 
 Second, the interpretation of these discharge measurements can only reliably be 
taken into consideration as a relative measure between experimental setups that differ in 
only one variable. Differences in terms of tip-to-inlet distance, applied voltage, and even 
instrumentation can affect the magnitude of these measurements. Non-discharging samples 
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acquired alongside the discharging sample of Figure 4 showed CO3
- measurements close 
to 0%, whereas a different set of conditions on a different instrument saw non-discharging 
samples produce CO3
- measurements around 0.5%. Additionally, some instruments may 
see background signal at the two ions observed, making those measurements less reliable. 
For example, the Q-Exactive Focus used in much of these experiments did not see a strong 
correlation between NO3
- signal and the presence of discharge, hence why the CO3
- signal 
alone was used to gauge discharge for all data presented. As will be seen, though, when 
used to compare similarly acquired samples, the CO3
- discharge measurements proved 
indispensable. 
Polyethylene Substrates 
 Recently reported was a negative ion PS-MS method for improved sensitivity in 
the detection of nitrobenzene and nitrophenol derivatives, achieved by using porous 
polyethylene (PE) and polyester (PES) as tip substrates.16 To investigate its discharge-
suppressing ability, PE was tested alongside paper as a PS substrate, and initial forays into 
this as a substrate were encouraging. As Figure 5 demonstrates, full-MS precursor ion 
intensities were slightly stronger and generally more precise when using methanol-washed 
Porex PE (7-12 μm pore size) instead of paper. This increase in signal was observed across 
three different sample matrices—methanol (neat), human whole blood, and bovine plasma, 
each containing ibuprofen and phenobarbital and spotted on paper punches—when tested 
with a methanol spray solvent containing ibufenac and phenobarbital-d5. Washing the tips 
with methanol first and allowing them to dry before use was found to increase precursor 
ion signal by ~2×, so it can be inferred that unwashed tips would present precursor ion 
intensities at about the same levels as paper tips. Additional porous PE substrates were 
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tested, including PE with larger pore sizes from the same manufacturer and high-density 
PE (HDPE) from a separate manufacturer, but none showed stronger signals than those 
which were obtained using the small-pore (7-12 μm) PE. 
 
Figure 5. Full-MS precursor ion intensities for ibuprofen, phenobarbital, ibufenac, and phenobarbital-d5 
sprayed from both paper and methanol-washed PE (7-12 μm pore size) tips across three different matrices 
(neat, human whole blood, and bovine plasma). Five replicates were run for each sample. 
 Continuing with the small-pore PE substrate, experiments were then performed to 
simulate quantitative conditions, such as what might be seen when preparing calibration 
curves. Phenobarbital and warfarin were tested in both neat and blood matrices at 
concentrations of 2000 ng/mL and 500 ng/mL, respectively, as well as at concentrations 
10× greater. A constant amount of an ISTD mixture containing both ibufenac and 
phenobarbital-d5 was added to each sample before spotting to allow for better quantitation. 
All samples were sprayed at 3.5 kV with the same conventional PS solvent—95:5:0.01 
methanol:water:acetic acid. 
 The raw MS/MS signals obtained for each of the four compounds in the most 
concentrated sample are shown in Figure 6. As can be seen, PE tips, though unwashed, 
actually saw a decrease in sensitivity that the precursor ions did not experience in full-MS. 
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The fact that the PE tips were unwashed is not likely to have been the cause for this decrease 
since the intensity of the precursor ions, and therefore the fragment ion signal, should have 
been approximately the same as with the paper tips; it would also fail to explain why 
phenobarbital-d5 in blood experienced such a drastic decrease in signal when sprayed from 
PE. Instead, the different experimental conditions between Figure 5 and Figure 6 were the 
likely cause for this loss in signal when transitioning to MS/MS. The spray solvents as well 
as the tip-to-inlet distances were different, and depending on how well PE sprays compared 
to paper, this could have affected the sensitivity. 
 
Figure 6. MS/MS fragment ion signal for phenobarbital, warfarin, ibufenac, and phenobarbital-d5 sprayed 
from both paper and unwashed PE (7-12 μm pore size) tips across neat and blood matrices. All samples were 
run in triplicate. 
 Furthermore, the average full-MS CO3
- signal across all paper samples was 1.06% 
of the TIC, with 8 out of 18 samples manifesting some amount of discharge during the 
acquisition that was reflected in the recorded spray current. For PE, the average CO3
- signal 
was 2.16%, with 14 out of 18 samples exhibiting high currents and visual discharge. These 
results would suggest that, despite the fact that a non-optimized spray solvent was used, 
PE was less capable than paper as a PS substrate when it came to suppressing discharge. 
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Figure 7. Ratio of analyte/ISTD signal for (a) phenobarbital and (b) warfarin at 1× and 10× their given 
concentrations of 2000 ng/mL and 500 ng/mL. All samples were run in triplicate; RSDs are given above or 
below each plot. 
 Figures 7a and 7b show the analyte/ISTD measurements for phenobarbital and 
warfarin, respectively. Phenobarbital, using an ideal SIL ISTD, saw better performance 
and precision spraying from paper than it did from PE, producing a narrow range of values 
that would in turn result in smaller errors when generating calibration curves. The largest 
relative standard deviation (RSD) for paper tips was at the lower concentration in blood, 
all others lying under 30%; RSDs from the PE tips were always above 50%, the largest 
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being 103%, which would hinder potential quantitation. Warfarin, on the other hand, saw 
less concrete differences between paper and PE in terms of RSDs. What was apparent, 
though, was that the warfarin/ibufenac measurements for the more concentrated sample 
were higher when using PE as opposed to paper, whereas the less concentrated samples 
were about the same. If used for actual quantitation, this would result in very steep 
calibration curves with a PE substrate, which would potentially correspond to increased 
sensitivity and lower LODs. 
 While the barbiturate data contradict the idea that PE provides enhanced detection 
in negative ion mode when used as a PS substrate, none of this is to refute the work 
presented by Wong et al.16 In their paper, the authors describe two mechanisms of negative 
ion formation, the first of which being electron-capture ionization. They observed that the 
ability to detect radical anions of nitrobenzene derivatives was proportional to a given 
compound’s electron affinity, which, with knowledge of the negative ESI circuit (Figure 
2a), suggests that the flow of electrons to the PS tip may have aided the production of 
analyte ions. Combined with the ability of PE to accumulate electrons—more so than 
paper, for example, owing to its greater electrostatic charging capabilities52—the increased 
sensitivity when detecting such radical anions may have given the appearance of resolving 
the discharge problem when in fact it was more of an analyte-specific effect that they were 
observing. Additionally, and perhaps more importantly, while Wong et al. were operating 
at a normal tip-to-inlet distance of 5 mm, they were also working within a low voltage 
range, between 1.4 and 1.6 kV. They mentioned that these low voltages were what aided 
the second mechanism of negative ion formation—deprotonation—for the improved 
detection of nitrophenol derivatives, commenting that PS above 3.0 kV in negative ion 
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mode, even with PE and PES, showed worse sensitivities than conventional ESI precisely 
because of the discharge problem. And since the aim of these studies was to develop a 
negative ion PS-MS method specifically to suppress corona discharge under the usual 3.5-
4.0 kV spraying conditions—the typical onset voltages required for proper and reliable 
Taylor cone formation which would allow for maximal sensitivity without having to rely 
on the vacuum of the MS for ionization53—alternative substrates alone were not the best 
avenue to approach such optimization. 
 Furthermore, it is important to note that in spite of what potential advantages PE 
may confer over paper when it comes to deprotonation and subsequent fragmentation, 
additional studies would be needed to optimize the specific substrate, examining in greater 
detail the effects and limitations of pore size. The PE substrate used most often here was 
one with a small pore size (7-12 μm). While this was easily cut into sharp tips, biofluids 
such as blood could not soak into it and would only bead up on the surface, preventing 
samples from being spotted directly onto the substrate; thick matrices had to first be spotted 
onto chromatography paper punches through which the spray solvent would travel before 
the substrate, such mixing of substrates potentially confounding results. Conversely, PE 
substrates with larger pore sizes (15-50 μm) were permeable to thick matrices like blood 
and were capable of being spotted, but they produced tips which were more prone to 
abrasive damage due to the less compact nature of the material. As such, the tips were more 
likely to have lost any semblance of being sharply pointed through handling or even the 
cutting process alone. This in turn generated microstructures at the tip which were small 
enough to see elevated electric fields beyond that which a single, sharp point would have 
produced, increasing the likelihood for discharge to occur and leading to more erratic and 
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unpredictable spraying. Because of this pore size dilemma when using PE as a PS 
substrate—combined with the poor quantitation demonstrated by it and the ready 
availability of paper-based cartridges for the automated Velox 360 PS-MS source—paper 
was used as the substrate for the remainder of the tests in the development of a negative 
ionization method to avoid discharge. 
Resistor-Aided Negative Ion Spray 
 Before optimizing the solvent, another method of discharge suppression was 
investigated, which was the inclusion of a 10-GΩ resistor in the high voltage line supplying 
the PS cartridge.47-49 In a normal ESI circuit, the air gap through which the solution sprays 
is the only effective resistor; when discharge occurs, this component breaks down into a 
conductor, resulting in the noticeable rise in spray current. By including a 10-GΩ resistor 
as a discrete component in the circuit before the tip, a backup resistor is established that 
can maintain a consistent current even if the air gap begins to break down, circumventing 
discharge entirely. This was observed by the fact that discharge could not be induced at 
short gap lengths or at applied voltages up to 8 kV, although voltages between 5 and 6 kV 
had to be used to initiate the electrospray process in the first place. As described earlier, 
the applied voltage and the tip-to-inlet distance are two of the most troublesome factors 
when trying to avoid discharge, so the ability to operate comfortably within a larger 
working range of voltages and over a more variable gap length allows for a greater amount 
of flexibility when it comes to optimizing a negative ion PS-MS method. 
 Due to this impressive discharge suppressing ability, initial tests incorporating the 
resistor were performed to measure MS/MS signal, recovery, and ion suppression relative 
to a PS-MS setup excluding the resistor, all on manual cartridges. Stable sprays were 
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achieved in the latter setup by using a pure methanol solvent base on well-cut paper tips at 
4.0 kV, achieving an average full-MS CO3
- signal of 0.5% among those samples which did 
not exhibit discharge. The raw signals obtained for each of the five compounds tested—
three analytes (ibuprofen, phenobarbital, and furosemide) at 10 μg/mL in the spotted 
sample and two ISTDs (ibufenac and phenobarbital-d5) at 1 μg/mL in the spray solvent—
in both neat and human whole blood matrices are shown in Figure 8. As can be seen, use 
of the resistor saw a slight decrease in signal, but never by more than a factor of 2, 
demonstrating comparable sensitivity which could potentially be improved by optimizing 
the applied voltage. Discharge was never visually observed in any of the resistor-
employing samples, with the measured full-MS CO3
- signal never rising above 0.5% in 
those that saw constant TIC. However, because of the inability to easily incorporate the 
resistor into the electronic system of the Velox 360 PS source (see Future Work), it was 
not used for the optimization of a negative ion PS-MS method. 
 
Figure 8. MS/MS fragment ion signal obtained for each of the five compounds in neat and whole blood 
matrices with and without use of the 10-GΩ resistor in the PS-MS circuit. Five replicates were run for each 
sample. 
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Discharge Susceptibility in Velox Sample Cartridges 
 To prepare for automation of PS-MS and eventual use of the Velox 360 PS source 
for the negative ion drug screen, a solvent composed of methanol with 0.01% NH4OH was 
used in spraying samples from both the manual cartridges with paper tips (Figure 3a) and 
the VSCs (Figure 3b), comparing both the discharge susceptibility between the two types 
of cartridges and the resulting analyte MS/MS signal. Samples containing several 
analytes—ibuprofen at 10000 ng/mL, naproxen at 30000 ng/mL, furosemide at 1000 
ng/mL, and three barbiturates, amobarbital, butabarbital, and butalbital, each at 500 
ng/mL—were tested in both neat and whole blood matrices. 
 The raw MS/MS signals obtained for these six analytes’ fragment ions are shown 
in Figure 9. Although the VSCs appeared to outperform the manual cartridges in a neat 
matrix, it should be noted that the spotting method for the latter only used 3.5 μL of sample 
while the former used 12 μL of sample, so the signal strength was comparable between the 
different cartridges overall. In spite of this, however, the barbiturates saw barely equivalent 
or lower signal, an effect more pronounced in blood. Samples diluted down to one-third 
and one-ninth of the screening cutoffs (see Table 1) produced similar trends in signals, but 
the barbiturates present in blood at 56 ng/mL were not detected at all when sprayed from 
the VSCs. 
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Figure 9. MS/MS fragment ion signal for ibuprofen (10000 ng/mL), naproxen (30000 ng/mL), furosemide 
(1000 ng/mL), amobarbital (500 ng/mL), butabarbital (500 ng/mL), and butalbital (500 ng/mL) in both neat 
and blood matrices, sprayed from manual cartridges and VSCs. All samples were run in triplicate. 
 One potential reason for lower signals may have been that the manual cartridges 
were sprayed at 4.0 kV while the VSCs were sprayed at 3.5 kV; the voltage had to be 
lowered by 500 V to accommodate the sharper paper tips in the VSCs, otherwise they 
would have only produced constant discharge. However, as can be seen in Table 2, 
discharge was still observed in both types of cartridges, even with a solvent base of pure 
methanol. The manual cartridges saw 14 of 36 samples discharge during acquisition, 
producing an average CO3
- signal of 0.89%; those samples which did not discharge 
generated an average CO3
- signal of 0.10%. The VSCs demonstrated a higher average CO3
- 
signal of 2.19%, with 26 of 36 samples discharging during the spraying process. 
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Table 2. Experimental parameters and discharge diagnostic data for manual cartridges and VSCs. 
Cartridge Type Manual VSC VSC 
Velox Source No No Yes 
Voltage [kV] 4.0 3.5 3.5 
Solvent [μL] 60 120a 142b 
Matrix   Neat     Blood     Neat     Blood     Neat     Blood   
No. of Samples 18 18 18 18 18 17 
No. Discharged 9 5 8 18 10 13 
CO3- Signal [%] 0.93 0.85 2.22 2.16 0.81 8.15 
a10 μL onto dried sample followed by 110 μL into the well of the VSC 
b12 μL onto dried sample (in 3-μL increments with delays (in seconds) of 24,2,2,2) followed by 130 μL into 
the well of the VSC (in 10-μL increments, all with delays of 2 seconds) 
 Even though a lower voltage was used, a curious effect was observed with the VSCs 
wherein they frequently exhibited discharge only in the moments before the Taylor cone 
was established, spraying normally after that point. These quick discharges occurred in 22 
of the 26 VSCs that discharged, leading to a range of full-MS CO3
- signals between 0.01% 
and 10.24% depending on the length of the latent period before proper Taylor cone 
formation. The middle half of this distribution, though, saw more representative CO3
- 
signals between 0.17% and 1.00%. While this wide spread of measurements may have 
artificially raised the amount of discharge measured in the VSCs, the fact that they 
discharged at all, even if only briefly, may explain the small drop in MS/MS signal. This 
phenomenon was also observed in some of the manual cartridges, although not nearly with 
the same frequency of occurrence and with a much weaker, more predictable effect on CO3
- 
signal. 
 Using the same solvent system of methanol with 0.01% NH4OH, the VSCs were 
also tested at 3.5 kV using the Velox source. This was done primarily to investigate the 
effects of both the solvent application via the source’s pump programming and the inability 
to manually set the tip-to-inlet distance. Since the solvent base was purely organic, large 
delays had to be incorporated into the pump programming to avoid excessive solvent 
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evaporation before sample acquisition. A delay of 24 seconds was used before the first 
application of solvent to the dried sample, followed by 2-second delays for the remaining 
solvent dispensations. The tip-to-inlet distance, as already described, largely influences the 
strength of the electric field at the tip, which in turn influences discharge susceptibility; by 
utilizing the automated Velox source for PS-MS and positioning it up against the rim of its 
mounting flange, control over this variable is relinquished. Such lack of control can be 
desirable as it allows for easier automation without user expertise, but it is also troublesome 
because being able to set the gap length is one of the few immediate ways of controlling 
discharge in negative ESI studies, hence the need to quantify the discharge experienced 
when using the PS source. 
 The discharge exhibited by these fully automated VSC tests is reflected in Table 2. 
On average, neat samples saw less severe but more frequent discharge than the non-
automated VSCs, but the discharge in blood samples was much more significant with an 
average CO3
- signal of 8.15%. While the pre-cone discharge that plagued the non-
automated VSCs was still observed with a similarly large range of discharge 
measurements, its frequency of occurrence was much lower, limited to only 4 of the 23 
samples that discharged. And compared to the analyte MS/MS signal obtained without 
automation (Figure 9), the only appreciable and negative difference from automated 
spraying was seen in the blood samples owing to the more intense discharge they 
experienced. 
Spray Solvent Optimization 
 When optimizing the spray solvent for PS-MS in negative ion mode, it was 
imperative to recognize that water should be excluded from the system entirely. The reason 
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for this is that including water increases the surface tension of the resulting mixture, which 
then requires higher onset voltages and field strengths to induce proper electrospray 
because stronger Coulombic forces are necessary to overcome the larger cohesive forces 
holding the solvent together.36,54 However, the onset of corona discharge occurs at the same 
field strength regardless, so the onset voltage for electrospray of a water-containing solvent 
sits closer to levels that will only produce discharge, creating a very small window of 
operating voltages in which electrospray can occur without discharge; pure water solvents 
genuinely never see a stable electrospray without the presence of corona discharge, even 
in positive ion mode.36 By only utilizing organic solvents as the base and adding trace 
amounts of modifiers as needed, the surface tension and, in turn, the onset potential for 
electrospray are kept low to maximize the range of operating voltages for stable spraying 
without incurring corona discharge. 
 As can be gathered from Table 2, it was apparent that despite the solvent base being 
pure methanol, discharge was still problematic for both manual cartridges and VSCs, 
especially so when automating the latter on the Velox PS source. Lowering the voltage 
further to 3.3 kV appeared to alleviate discharge and allow for consistency between 
samples, but the same experimental conditions on a different day saw constant discharge 
in every sample. This probably occurred because the applied voltage was close enough to 
the onset potential for corona discharge that slight day-to-day variances in operating 
parameters were significant—a more robust approach was clearly required. Electron-
scavenging cosolvents, which actively suppress discharge by raising the onset potential at 
which it occurs, were turned to next. To this end, chlorine-containing solvents—primarily 
carbon tetrachloride (CCl4)
2,45,46—were paired with methanol and the discharge-
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suppressing abilities of the resulting mixtures were investigated, with the results presented 
in Figure 9 and Table 2 serving as a baseline for measuring success in this regard. 
Chloroform (CHCl3) was also tested as a potential cosolvent, but the discharge suppression 
it offered was not as strong as that of CCl4, so only the latter was used in the solvent 
optimization. 
 Initially, solvents containing varying amounts of CCl4—between 0.01% and 10%, 
with the rest of the solvent being composed of methanol and 0.01% NH4OH—were tested 
against each other to gauge how much CCl4 would be required to adequately suppress 
discharge. Run on manual cartridges with neat samples at 3.3 kV, the distributions of 
discharge measurements from these solvents are shown in Figure 10. Since a lower voltage 
was used than in Table 2, the spray solvent with no CCl4 saw smaller measured amounts 
of discharge. The frequency of samples that discharged with this solvent, however, was 
still the same, with every other sample exhibiting discharge at some point during the 
acquisition. 
 
Figure 10. Full-MS CO3- measurement distributions for spray solvents containing different amounts of CCl4. 
The remaining solvent consisted of methanol with 0.01% NH4OH, spraying from neat samples on manual 
cartridges at 3.3 kV. Eight replicates were run with each spray solvent. 
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 As can be seen, utilizing lower amounts of CCl4 appeared to worsen the 
reproducibility between samples. While they generally saw a progressive decrease in the 
lower limit of the CO3
- measurements, their average discharge measurement was higher 
than when CCl4 was excluded from the solvent entirely. However, when CCl4 was included 
at levels as high as 5% or 10%, the discharge suppression became readily apparent, 
generating average full-MS CO3
- signals of 0.13% and 0.09%, respectively. Some of the 
samples tested with these two solvents did discharge, but those arose mainly from a lack 
of solvent rather than genuine spray instability, discharging only at the end when the spray 
solvent on the paper tip ran dry and the Taylor cone collapsed. To maintain good discharge 
prevention capabilities at applied voltages up to 4.0 kV, 10% CCl4 was used for the 
remainder of the tests instead of 5% CCl4. 
 When transferred to VSCs spotted with blood and run using the Velox 360 PS 
source (3.5 kV onset voltage, 142 μL of solvent), the capability of the 10% CCl4 solvent in 
suppressing discharge became even more pronounced. Compared to the 8.15% CO3
- signal 
seen in blood with a CCl4-excluding solvent (Table 2), the 10% CCl4 solvent’s CO3- signal 
never rose above 0.01% across 29 samples, averaging out at 0.00%. Furthermore, none of 
the samples saw spray currents >1 μA, indicating that the solvent with 10% CCl4 
(90:10:0.01 methanol:CCl4:NH4OH)—when applied as 12 μL onto the DBS via pump A 
and 130 μL into the VSC well via pump B with appropriately set timing delays in the pump 
programming to avoid evaporation—was able to entirely prevent discharge over spraying 
times of at least 72 seconds, establishing it as the optimized solvent for negative ion PS-
MS. 
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 To highlight the effects of optimizing the solvent to include CCl4 as a significant 
component, Figure 11 shows the amount of discharge (measured via CO3
- signal) 
encountered compared to two other solvents—100:0.01 methanol:NH4OH and 95:5:0.01 
methanol:water:acetic acid—across 35 VSCs sprayed at 3.5 kV from the Velox 360 source. 
While methanol was able to lower the average discharge measured, it did not prevent all 
discharge, leading to some measurements >1%. When 10% CCl4 was added to the solvent, 
all discharge measurements were <0.05% except for 2 of the 35, which still lay <0.5%. 
These exceptions were likely caused by imperfections on the VSCs’ paper tips; if excluded, 
the distribution of discharge measurements for the optimized solvent would be narrower 
and the average would be shifted down. Nonetheless, the difference in discharge 
measurements provided by the optimized solvent as opposed to the methanol solvent was 
verified with a heteroscedastic t-test, where the former produced lower CO3
- measurements 
with 95% confidence. Compared to the conventional solvent, it produced less discharge 
with >99% confidence. 
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Figure 11. Comparison of discharge measurements between the optimized solvent (90:10:0.01 
methanol:CCl4:NH4OH), a methanol solvent (100:0.01 methanol:NH4OH), and a conventional PS solvent 
(95:5:0.01 methanol:water:acetic acid), all run at 3.5 kV on the Velox 360 source. 35 replicates were run with 
each spray solvent. 
 These same three solvents were also used to compare the precision of analyte/ISTD 
measurements between 30 VSCs spotted with blood samples containing 
hydrochlorothiazide, phenobarbital, and pentobarbital—all at their screening cutoffs (see 
Table 1) or lower—as well as the ISTDs ibufenac (for hydrochlorothiazide) and 
phenobarbital-d5 (for phenobarbital and pentobarbital). The distributions of these 
measurements are shown in Figure 12, with the optimized solvent prominently displaying 
lower RSDs for each drug. While the precisions of the other two solvents are not as 
important to take note of, it is worth drawing attention to the poor performance of 
barbiturates when sprayed with the methanol solvent compared to the conventional solvent; 
this was due to phenobarbital-d5 not being detected in many of the samples sprayed with 
methanol, subsequently returning values of zero for the phenobarbital/pentobarbital 
measurements. Regardless, the optimized solvent outperformed both of the other solvents 
at a single concentration. 
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Figure 12. Ratio of analyte/ISTD signal for hydrochlorothiazide, phenobarbital, and pentobarbital acquired 
using (1) the optimized solvent (90:10:0.01 methanol:CCl4:NH4OH), (2) a pure methanol solvent (100:0.01 
methanol:NH4OH), and (3) a conventional PS solvent (95:5:0.01 methanol:water:acetic acid). 30 replicates 
were run with each solvent; RSDs are given above each plot. 
 To further test the quantitative capabilities of the optimized solvent, phenobarbital 
and warfarin were sprayed from manual cartridges at 3.5 kV in a similar manner to what 
was shown in Figure 7, this time comparing the solvent to a conventional one (95:5:0.01 
methanol:water:acetic acid) using only paper tips. The results of these analyte/ISTD 
measurements in blood samples are shown in Figure 13. Through the three replicates that 
were tested at each concentration, the optimized solvent saw better RSDs in all but 
phenobarbital at 20000 ng/mL (10×), demonstrating its potential for more reliable 
quantitation, especially around lower concentrations. 
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Figure 13. Ratio of analyte/ISTD signal for phenobarbital and warfarin at 1× and 10× their given 
concentrations of 2000 ng/mL and 500 ng/mL in blood, sprayed using the optimized solvent (90:10:0.01 
methanol:CCl4:NH4OH) and a conventional solvent (95:5:0.01 methanol:water:acetic acid). All samples 
were run in triplicate; RSDs are given above each plot. 
 Additionally, through the inclusion of 10% CCl4 in the spray solvent, the onset 
potential of corona discharge for the VSCs on the Velox source was effectively pushed up, 
allowing access to a greater range of operating voltages for normal, discharge-free ESI. At 
4.0 kV—a voltage that caused nothing but constant discharge with a pure methanol solvent 
and generated full-MS CO3
- measurements >25%—the optimized solvent succeeded at 
completely preventing discharge; of 20 blood-spotted VSCs that were tested at this 
heightened voltage, none saw discharge-level spray currents and all produced CO3
- 
discharge measurements <0.1%. Paired with the strategy of setting large delays in the 
Velox 360 pump programming for dispensing 142 μL of solvent, this 90:10:0.01 
methanol:CCl4:NH4OH solvent at 4.0 kV was treated as the fully optimized method for 
negative ion mode and as such was used for the negative ion PS-MS drug screen. 
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Negative Ion Drug Screen 
 The calibration curves generated from the negative ion drug screen are summarized 
in Table 3, with those of the barbiturates shown in Figure 14. As can be seen, with the 
exception of pentobarbital, the barbiturates performed well in this optimized negative ion 
PS-MS method, generating R2 values >0.95 and relative errors in slope <7%. The likely 
limiting factor as regards their calculated LODs was the screening cutoff concentration 
used as the lowest calibrant (see Table 1); the selective and sensitive power of the Q-
Exactive Focus mass spectrometer could potentially allow for even lower concentrations 
to be used and reliably detected in the calibration series, driving LODs down further. 
Altogether, these data indicate the success of utilizing phenobarbital-d5 not only as an 
ISTD, but as a general ISTD for all heterocyclic imides or structurally similar compounds. 
Table 3. Calibration curve data for each analyte from the negative ion drug screen. Screening cutoffs can be 
found in Table 1. 
Analyte ISTD 
LOD 
[ng/mL] 
Rel. Error in 
Slope [%] 
R2 
Butabarbital Phenobarbital-d5 229 3 0.99 
Butalbital Phenobarbital-d5 263 4 0.98 
Amobarbital Phenobarbital-d5 321 5 0.97 
Pentobarbitala Phenobarbital-d5 1821 26 0.52 
Phenobarbital Phenobarbital-d5 502 4 0.98 
Secobarbital Phenobarbital-d5 286 4 0.98 
Thiopental Phenobarbital-d5 1100 4 0.98 
Phenytoin Phenobarbital-d5 919 7 0.95 
Salicylic acid Ibufenac 8572 7 0.94 
Valproic acid Ibufenac 24315 35 0.38 
Levetiracetam Ibufenac 8338 30 0.46 
Ibuprofen Ibufenac 3997 29 0.48 
Naproxen Ibufenac 3010 22 0.62 
Hydrochlorothiazide Ibufenac 130 9 0.90 
Warfarin Ibufenac 674 10 0.89 
Furosemide Ibufenac 1370 10 0.89 
Tadalafil Ibufenac 187 14 0.81 
Ethyl sulfate Ibufenac 125 9 0.90 
Ethyl-beta-D-glucuronide Ibufenac 461 34 0.41 
aRun in a separate set of samples, the calibration curve for pentobarbital had a relative error in slope of 8% 
and an R2 value of 0.94, generating a detection limit of 561 ng/mL 
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Figure 14. Calibration curves for (a) butabarbital, (b) butalbital, (c) amobarbital, (d) pentobarbital, (e) 
phenobarbital, (f) secobarbital, (g) thiopental, and (h) phenytoin. The y-axes are the ratio of the respective 
fragment ion signal to that of phenobarbital-d5, and each point is the average of three replicates of these 
measurements. Inset in (d) is a calibration curve for pentobarbital run from a different set of samples. 
41 
 Comparatively, pentobarbital appeared to perform very poorly, owing largely to an 
exaggerated heteroscedastic effect observed in the analyte/ISTD measurements—the 
spread of the data at higher concentrations was noticeably disproportionate to the spread 
of the data at lower concentrations. Because of the poor quality of the calibration curve, 
the calculated LOD was almost 4× the screening cutoff of 500 ng/mL. While far from 
perfect, these results may simply be chalked up to poor individual data acquisitions rather 
than an incapability of the method in detecting pentobarbital for a number of reasons. First, 
there were no issues with detecting it at the screening cutoff, and it was not detected in the 
blank matrix at all. Secondly, amobarbital, which is a structural isomer to it and even 
fragments into the same daughter ion (Table 1), failed to see such shortcomings with its 
quantitative performance (Figure 14c). Thirdly, the other barbiturates which were present 
in the sample with pentobarbital—phenobarbital, secobarbital, thiopental, and phenytoin—
did not appear to suffer from poor quantitation, indicating that the measured phenobarbital-
d5 signal was not the source of the problem. And lastly, previous experiments using the 
same calibration series and data processing procedure saw significantly improved 
pentobarbital quantitation, as indicated after Table 3 and in the calibration curve inset in 
Figure 14d—the only difference was that a greater amount of ISTD was used. These 
reasons suggest that further experiments would likely not encounter this anomaly again. 
 Those analytes which used ibufenac as an ISTD saw generally worse performance 
in the drug screen than the barbiturates. While some of these compounds—namely salicylic 
acid, hydrochlorothiazide, warfarin, furosemide, tadalafil, and ethyl sulfate—saw adequate 
quantitation with relative errors in slope <15%, the rest displayed no ostensibly linear trend 
in the data. For example, ibuprofen, for which ibufenac was a direct structural analog and 
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therefore a theoretically acceptable ISTD, failed to produce any semblance of reliable 
quantitation, generating the calibration curve seen in Figure 15 with a relative error in slope 
of 29% and an R2 value of 0.48. 
 
Figure 15. Calibration curve for ibuprofen in blood samples. 
 Most of the drugs that exhibited such poor quantitation did so either because the 
MS/MS signal did not noticeably change with concentration or because there was a high 
background signal in the matrix that obscured any true signal. As can be seen in Figure 
16a, ibuprofen was not significantly detected in the blank matrix, but its signal effectively 
did not change over the concentration range tested. This may be a limitation of the method 
in that it cannot quantitatively detect such low concentrations of ibuprofen, requiring 
larger, more toxicologically relevant concentrations to obtain satisfactory calibration (see 
Future Work). Levetiracetam, on the other hand, saw high MS/MS signal in the blank 
matrix at about the same level as the calibration samples, as shown in Figure 16b; ethyl-
beta-D-glucuronide, a metabolite of ethanol, experienced a similar problem. Ethyl sulfate, 
another ethanol metabolite, saw background signals as well, but they were not high enough 
to interfere with those generated by the calibration samples, leading to its acceptable 
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quantitation and the conclusion that it rather than the glucuronide may be better suited for 
biomonitoring of ethanol use. 
 
Figure 16. Raw MS/MS signal for (a) ibuprofen and (b) levetiracetam in the matrix blanks and calibration 
samples. 
 These high backgrounds at some of the observed fragment ions combined with the 
fact that certain compounds did not fragment well in the first place—valproic acid, for 
instance, did not fragment at all, so its precursor ion had to be used for all MS/MS 
measurements—suggests that the non-barbiturate side of the drug screen itself requires 
further optimization beyond just the negative ionization aspect of the method. Regardless 
of these poor calibration curves, though, the optimized method for PS-MS in negative ion 
mode was, if nothing else, demonstrated in the successful quantitation of barbiturates as 
well as several other acidic analytes. 
Future Work 
 While including 10% CCl4 in the spray solvent was shown to generate stable and 
reproducible sprays in negative ion mode, there are several drawbacks to its application 
outside of research, chief among those being that it is classified as an ozone-depleting 
substance under the Montreal Protocol as part of the Vienna Convention for the Protection 
of the Ozone Layer55 and is regulated as such. Additionally, its acute toxicity poses not-
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insignificant safety hazards to the user when aerosolized—it can metabolize and thermally 
degrade into phosgene, for example56,57—and it is considered a possible carcinogen by the 
International Agency for Research on Cancer (IARC).58 And when processing a large 
number of samples that require bulk amounts of spray solvent—with the compound in 
question comprising 10% of it—there is an economic factor to be considered, which is 
made more dramatic when used for PS-MS, which is noted for its use of inexpensive 
materials designed for affordable replicate sampling. 
 Future research into bettering the performance of negative ion PS-MS could explore 
the inclusion of other analytes in the spray solvent that are not as regulated or hazardous 
as CCl4 and can more efficiently suppress corona discharge, potentially requiring amounts 
totaling to less than 10% of the solvent volume. One such compound is 7,7,8,8-
tetracyanoquinodimethane (TCNQ), which has an electron affinity of 2.8 eV.59 Compared 
to the 0.8 eV electron affinity of CCl4,
60 this suggests that it may act as a better and more 
efficient electron scavenger, further increasing the range of operating voltages that can be 
accessed in negative ion mode without seeing discharge. TCNQ has already been shown 
to generate reproducible negative ion sprays at higher-than-usual onset voltages with a 
solvent base of 98:2 acetone:acetonitrile,44 indicating that it may be useful for further 
optimization of negative ion PS-MS. 
 Along these lines, other organic-soluble analytes with electron affinities >0.8 eV 
would be worthwhile to examine with respect to their discharge-suppressing capabilities. 
Another compound that might be useful in this regard is hexachloroethane, C2Cl6. Not 
regulated by the Montreal Protocol, this would follow in the veins of previous research into 
the use of chlorine-containing solvents for negative ESI.2,45,46 While its precise electron 
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affinity is not confidently known and its chlorine content is about the same as CHCl3, the 
larger amount of chlorine atoms alone may give it an advantage over CCl4 in terms of its 
ability to suppress discharge. However, C2Cl6 is also classified as possibly carcinogenic to 
humans by the IARC58 and has its own toxicity-related hazards, so its utility in negative 
ion PS-MS may need to be weighed against the associated safety risks. 
 In terms of the solvent base, different organic solvents could be tested to measure 
how well they suppress discharge and support analyte MS/MS signal. Isopropanol was 
briefly tested in this regard, and while its use as a solvent with 0.01% NH4OH showed a 
decrease in full-MS precursor ion signals compared to a pure methanol solvent, a 50:50 
mixture of methanol:isopropanol actually showed slightly improved sensitivity for certain 
MS/MS fragment ions when performing automated PS-MS. Furthermore, the CO3
- 
discharge signal in this 50:50 methanol:isopropanol solvent was found to be less severe 
than when using a pure methanol solvent, with discharge occurring less frequently as well. 
It did not reach near the levels of discharge suppression that were achieved through the 
inclusion of 10% CCl4 in the spray solvent (Figure 10 and Figure 11), but it may be 
worthwhile to investigate further to potentially lessen the amount of CCl4 required to 
sufficiently quench the discharge problem. 
 Non-conventional substrates—not just PE—could also be further tested in the 
development of a negative ion PS-MS method. Initial experiments on the small-pore PE 
and paper using the optimized solvent did not see much of a change in quantitative 
capabilities compared to what was seen in Figure 7, but resolution of the pore size dilemma 
may prove otherwise. Additionally, as mentioned earlier, only operational voltages above 
3 kV were used in these experiments, so lower voltages could be tested to determine if it 
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can prevent discharge as much as or more effectively than the optimized solvent and if it 
can achieve sensitivities and accurate quantitation for target compounds such as 
barbiturates in negative ion mode, for which the information contained in Table 3 will 
prove invaluable. 
 In light of the data shown for the inclusion of a 10-GΩ resistor in series with the 
high voltage line supplying the PS process, the technique to avoid discharge when 
operating in negative ion mode seemed to work without negatively affecting sensitivity. 
However, bearing in mind the desire to automate PS-MS, a major impediment to furthering 
this as an avenue of discharge suppression is that the required resistor modification would 
have to be a manufacturer-end addition. There are numerous ways this additional resistance 
could be worked into the current model of the Velox 360 PS source: inclusion in the source 
itself with a switch that can be flipped on or off depending on whether or not negative 
ionization is occurring; permanent incorporation into the circuitry in the source with the 
expectation of always operating at higher onset voltages when in use; or as an add-on that 
can be manually connected to the high-voltage line when negative ionization is desired. 
Regardless, the use of the resistor in these experiments was atypical of the type of user-end 
control designed for the PS source, which is meant to lie primarily with the solvent choice 
and its application to the cartridges through pump programming. 
 Regarding the negative ion PS-MS drug screen, additional work needs to be done 
to improve the performance of drugs such as ibuprofen, naproxen, levetiracetam, and 
valproic acid. Even when quantitated using phenobarbital-d5, these problematic analytes 
saw no improvement, signifying the problem as primarily analyte-based. It is worth 
mentioning that the given screening cutoffs for ibuprofen and naproxen were lowered by 
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10× and 30× for the purposes of generating these calibration curves—as opposed to the 
1000 ng/mL used, the original cutoffs were 10000 ng/mL and 30000 ng/mL, respectively—
to make their inclusion in blood samples along with other analytes more manageable, so 
they may see successful quantitation at such higher and more toxicologically relevant 
concentrations. Also, different matrices could be tested for quantitation, seeing if biofluids 
such as urine or blood plasma, or even a neat matrix, see as much trouble when quantitating 
drugs like ibuprofen, naproxen, levetiracetam, and valproic acid. 
Conclusion 
 When using conventional PS-MS solvents in negative ion mode, there is a very 
narrow voltage range, nestled between the onset of electrospray and the onset of corona 
discharge, over which stable spray can be achieved, but even then only with questionable 
reproducibility. By using the CO3
- (m/z 60) measurements in full-MS scans, discharge was 
effectively quantified to monitor how well any given technique suppressed it, provided the 
method generated a constant signal in the first place. While the use of PE as a substrate 
saw worse performance than paper, two techniques were found to sufficiently suppress 
discharge to allow for better sensitivity and accurate quantitation: (1) inclusion of a 10-GΩ 
resistor in the high voltage line supplying the PS source, and (2) optimization of the spray 
solvent to 90:10:0.01 methanol:CCl4:NH4OH. By altering the solvent to include larger 
amounts of CCl4, the potential required to reach the onset of discharge was effectively 
pushed up, allowing for a larger working range of voltages that in turn improved the ability 
to spray consistently from sample to sample. 
 Using the optimized solvent alone as the discharge-preventing method, the ability 
to accurately quantitate several analytes was demonstrated using the automated Velox 360 
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PS source. Taking the problem with pentobarbital into consideration, the negative ion 
method worked exceptionally well for barbiturate detection, generating calibration curves 
with relative errors in slope <7% and LODs lower than the screening cutoffs, with 
suggested potential for better trace detection. Recoveries from blood relative to neat 
samples for the barbiturates were ~30%. Additional analytes such as salicylic acid, 
warfarin, furosemide, and ethyl sulfate showed adequate quantitation with ibufenac, 
exhibiting its adaptability as a generic ISTD, but, with the exception of salicylic acid, their 
calculated LODs still lay above the screening cutoffs. Ibuprofen, naproxen, levetiracetam, 
valproic acid, and ethyl-beta-D-glucuronide all saw poor calibration, a result of 
concentration-independent MS/MS signal, high background signal in the matrix, and poor 
fragmentation. These shortcomings, however, lie with the drug screen itself rather than the 
ionization method, and as such require attention beyond the intended purpose of this study. 
 In Chapter 3, this same negative ion PS-MS method, optimized to suppress 
discharge, will be applied to the detection of chemical warfare agent hydrolysis products, 
ultimately showing how well it compares to a positive ion PS-MS method.
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CHAPTER 3. DETECTION OF CHEMICAL WARFARE AGENT 
HYDROLYSIS PRODUCTS USING PS-MS 
Author’s Note 
 The information contained within the Materials and Methods, Results and 
Discussion, and Conclusion sections has been reproduced from McKenna et al. (DOI: 
http://dx.doi.org/10.1039/C7AN00144D)61 by permission of The Royal Society of 
Chemistry. 
Introduction 
 Ever since their initial discovery and later weaponization in World Wars I and II as 
well as in the Iran-Iraq War in the 1980s,62,63 the use of chemical warfare agents (CWAs) 
has been a subject of heated contention both politically and ethically. While attempts were 
made by the United Nations in the 1990s to curb the production, stockpiling, and use of 
CWAs through the Chemical Weapons Convention (CWC),64 they still remain relevant 
today, as evidenced by their use in the Tokyo subway attacks perpetrated by the Aum 
Shinrikyo cult in 1995,65-68 their suspected role in the assassination of a North Korean exile, 
Kim Jong-nam, in 2017,69 and their recent reported use on Syrian civilians in both 2013 
and 2017.70-73 
 CWAs are organized into several categories depending on their effects, such 
categories including riot-control agents, choking agents, blood agents, and blistering 
agents. Another family of CWAs are known as nerve agents, which are acutely toxic 
organophosphonate compounds that negatively affect the nervous system by inhibiting 
acetylcholinesterase activity; this leads to a buildup of acetylcholine in nerve cells and 
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prevents muscles from relaxing, ultimately causing death from respiratory paralysis.74-76 
Nerve agents are divided into two major categories: G- and V-series agents, which are 
differentiated primarily by their chemical structures, the former containing either a fluorine 
or cyanide substituent and the latter containing a thioalkyl substituent. Five such nerve 
agents—O-isopropyl methylphosphonofluoridate (GB, sarin), O-pinacolyl 
methylphosphonofluoridate (GD, soman), O-cyclohexyl methylphosphonofluoridate (GF, 
cyclosarin), O-ethyl-S-(2-diisopropylamino)ethyl methylphosphonothiolate (VX), and O-
isobutyl-S-(2-diethylamino)ethyl methylphosphonothiolate (VR, “Russian VX”)—are 
shown in Figure 17. 
 
Figure 17. Chemical structures of five nerve agents: GB (sarin), GD (soman), GF (cyclosarin), VX, and VR 
(“Russian VX”). 
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 Detection of CWAs in biological and environmental samples is important for 
several reasons. In the event of exposure to such toxic compounds, rapid identification of 
the agent responsible is crucial both to providing immediate and appropriate medical 
treatment for any victims77,78 as well as to directing emergency response in the handling 
and management of the attack site.79 Monitoring adherence to the CWC, especially along 
the lines of destroying weapon stockpiles and investigating suspected sites of mass CWA 
production, is necessary for maintaining international agreements and relationships. 
Additionally, biomonitoring of personnel responsible for decontaminating and cleaning up 
CWA production sites is vital to ensuring that proper and sufficient safety protocols are 
being followed. 
 Over the past 20 years, numerous methods—most utilizing MS—have been shown 
to be successful in the detection of CWAs. LC-MS has been effective in analyzing CWAs 
present in environmental samples such as water and soil, with liquid extractions usually 
performed on solid samples.80,81 However, since intact CWAs are volatile and thermally 
stable, they are particularly well-suited for GC-MS analyses; while a typical extraction 
from a soil sample followed by GC-MS was on par with LC-MS detection,80 solid-phase 
microextraction (SPME) sampling coupled with GC-MS analysis was able to achieve 
LODs down to 0.05-1 ng/mL from environmental water samples.82 Ambient ionization 
techniques have also been appealing in CWA analysis, predominantly because of the 
minimal requirements in the way of sample preparation and the fieldability of the 
instrumentation. To this end, atmospheric pressure chemical ionization (APCI) MS has 
been used for air samples83,84 and DART-MS has shown good quantitation from both clean 
and muddy water samples.6,85 DESI-MS has also proven useful when combined with SPME 
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sampling from office media (i.e., carpet, upholstery, printer paper, cotton swabs), 
demonstrating detection of CWAs at 1 μg/g quantities and lower as well as showing 
contaminant identification from a munitions-grade sample of VX.86,87 
 Aside from the analysis of pesticides and herbicides—which are chemically similar 
to CWAs—from food and environmental samples,28,88 no work has been done toward using 
PS-MS for the detection of CWAs. A recent study, however, examined the nerve agent 
simulants dimethyl methylphosphonate (DMMP), diisopropyl methylphosphonate 
(DIMP), and trimethyl phosphate (TMP) using PS-MS and quantitated their detection in 
biological samples.61 The paper spray technique was capable of detecting these simulants 
at concentrations between 1-25 ng/mL in urine and 10-40 ng/mL in blood. Furthermore, 
the authors demonstrated that successful quantitation could be achieved without any direct 
sample preparation at all, achieving comparable LODs and linear calibration curves when 
the ISTDs were spiked directly onto the dried sample spot on the VSC rather than spiking 
them into the sample before spotting. 
 While detecting intact CWAs is important, it is often not feasible when testing real 
biological samples due to chemical degradation. All CWAs shown in Figure 17, when 
present in bodily fluids, quickly undergo hydrolysis according to the first reaction in Figure 
18, producing alkyl methylphosphonic acids (alkyl MPAs) depending on the identity of the 
R group. To this end, sarin produces isopropyl MPA (IMPA), soman produces pinacolyl 
MPA (PinMPA), cyclosarin produces cyclohexyl MPA (CHMPA), VX produces ethyl 
MPA (EMPA), and VR produces isobutyl MPA (iBuMPA).76 These alkyl MPAs then 
undergo further hydrolysis to form MPA via the second, much slower reaction shown in 
Figure 18. Because of this rapid hydrolysis of the intact nerve agents, they are rarely ever 
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detected in biological samples, instead making the hydrolysis products useful for any 
analyses. For example, in blood samples collected from victims of the Tokyo subway sarin 
attack 1.5-2.5 hours after exposure, sarin itself was not detected in the serum, but IMPA 
was detected at concentrations ranging from 2-135 ng/mL.67 
 
Figure 18. Successive hydrolysis reactions of a CWA, where X = F or S(CH2)2NR’2 and R = C2-C6. 
 The detection of these hydrolysis products in several media has been previously 
shown using several methods. Unlike the intact CWAs, though, they do not volatilize well, 
making GC-MS analyses difficult because they require derivatization first, which is both 
time-consuming and complicates attempted quantitation.89,90 With derivatization, GC-MS 
was able to detect the alkyl MPAs in soil and diesel samples down to absolute quantities 
of 200-500 pg.91 Although they generally see worse quantitative performance than their 
GC counterparts—achieving LODs between 10-100 ng/mL—LC- and HPLC-MS 
techniques have more frequently been used for qualitative detection of the alkyl MPAs 
from environmental samples.92-96 An ambient ionization technique, reactive DESI-MS was 
used in the detection of EMPA, IMPA, and MPA from biological and complex matrices 
on glass and polytetrafluoroethylene surfaces, achieving sub-ng detection limits for all.97 
No studies, however, have investigated the detection of the CWA hydrolysis products using 
PS-MS. 
 Since the alkyl MPAs are acidic, the goal of this study was to take the optimized 
negative ion method from Chapter 2 and apply it to the PS-MS detection of EMPA, IMPA, 
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iBuMPA, CHMPA, and PinMPA in biological samples. These five compounds were also 
detected using positive ionization for purposes of comparison and to determine which 
polarity offered superior sensitivity and quantitative accuracy. The potential is 
demonstrated for the application of PS-MS detection of CWA hydrolysis products to 
fieldable instrumentation, which would allow for rapid analyses of biological samples to 
provide valuable information when responding to nerve agent attacks. 
Materials and Methods 
Chemical Materials 
 Ultra-high-performance liquid chromatography (UHPLC) grade methanol, Optima 
grade ammonium hydroxide, and formic acid were purchased from Fisher Scientific 
(Pittsburgh, PA, USA). Anhydrous carbon tetrachloride was purchased from Sigma 
Aldrich (St. Louis, MO, USA). Mixtures of EMPA, IMPA, iBuMPA, CHMPA, and 
PinMPA dissolved in water were purchased from Cerilliant (Round Rock, TX, USA—
product number NAx8-CAL). A mixture of SIL analogs of the hydrolysis products—
d5EMPA, 
13C3IMPA, 
13Cd3iBuMPA, 
13C6CHMPA, and 
13C6PinMPA dissolved in water—
was also purchased from Cerilliant (product number NAx8-IS). Human whole blood and 
urine were provided by a single donor. 
Sample Preparation 
 Solutions containing the CWA hydrolysis products were purchased in 
concentrations of 5000, 2500, 1250, 625, 250, 125, 63, and 25 ng/mL. Calibration standards 
were then prepared in blood or urine at concentrations of 250, 125, 62.5, 31.25, 12.5, 6.25, 
3.15, and 1.25 ng/mL by performing 1:20 dilutions of the aqueous working solutions in the 
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biological matrix. A 5-μL aliquot of an aqueous ISTD solution was spiked into a 100-μL 
aliquot of each biological sample; the ISTD solution contained 525 ng/mL of each of the 
five SIL CWA hydrolysis products. 
Paper Spray Ionization 
 All samples were spotted (12 μL) on VSCs and sprayed using the Velox 360 
automated PS source (Prosolia, Indianapolis, IN, USA). When using positive ionization, 
95:5:0.01 methanol:water:formic acid was used as the spray solvent. To reduce the 
propensity for discharge and encourage ion formation when operating in negative ion 
mode, 90:10:0.01 methanol:CCl4:NH4OH was used as the spray solvent. Pump A was 
programmed to dispense 3 μL four times and pump B was programmed to dispense 10 μL 
thirteen times, using 142 μL of solvent total. For both polarities of ionization, the solvent 
pump programming was spread out over the course of 1.4 minutes, with the negative ion 
mode program utilizing smaller delays between subsequent pumps to prevent excessive 
solvent evaporation. 
Mass Spectrometry 
 All data were acquired on a Q-Exactive Focus orbitrap mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA, USA) with the S-lens set to 50 and capillary temperature 
set to either 325°C or 320°C for positive or negative ion modes, respectively. The 
instrument methods were both 1.4 minutes long with the spray voltage on at +4.0 kV or 
−4.0 kV (depending on the method-specified polarity) from 0–1.1 min, the voltage then 
being set to 0 kV from 1.1–1.4 min; the spray voltage was turned off to give zero-intensity 
scans, a requirement for automatic peak integration. The mass spectrometer was operated 
solely in MS/MS mode using an inclusion list with an isolation width of ±0.5 m/z in the 
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first quadrupole to filter precursor ions. The precursor and fragment ions for the five 
hydrolysis products and their SIL analogs, as well as the optimized CE for each 
fragmentation, can be found in Table 4, and the negative ion transitions are shown in Figure 
19. 
 
Figure 19. Negative ion transitions of the five CWA hydrolysis products. Red and blue bolded atom labels 
indicate the locations of the 2H (d) and 13C isotopes, respectively, in the SIL analogs. 
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Table 4. Fragmentation of each CWA hydrolysis product and their SIL ISTDs for both positive and negative 
ion MS/MS, the latter of which is highlighted. 
Compound Adduct Precursor Ion [m/z] Fragment Ion [m/z] CE [V] 
EMPA 
+H 125.0364 97.0055 10 
-H 123.0212 94.9896 12 
d5EMPA 
+H 130.0679 98.0117 11 
-H 128.0529 94.9897 14 
IMPA 
+H 139.0506 97.0055 10 
-H 137.0371 94.9896 14 
13C3IMPA 
+H 142.0619 97.0055 12 
-H 140.0473 94.9896 14 
iBuMPA 
+H 153.0675 97.0055 16 
-H 151.0528 94.9895 16 
13Cd3iBuMPA 
+Na 179.0719 73.0292 13 
-H 155.0752 99.0118 15 
CHMPA 
+Na 201.0650 118.9872 13 
-H 177.0683 94.9896 23 
13C6CHMPA 
+Na 207.0851 118.9871 10 
-H 183.0885 94.9896 20 
PinMPA 
+Na 203.0808 118.9871 12 
-H 179.0840 94.9896 21 
13C6PinMPA 
+Na 209.1007 118.9871 10 
-H 185.1042 94.9896 19 
 
Data Processing 
 All data were automatically processed using TraceFinder v. 3.3 (Thermo Fisher 
Scientific). Peaks within a 5-ppm window of the target compound’s fragment ion were 
integrated. The analyte peak area was divided by the area of the corresponding fragment 
ion of the appropriate ISTD. Each calibration point was run in triplicate and the ratios of 
analyte signal to ISTD signal were plotted against their known concentrations to generate 
the calibration curve, which was linearly fit using 1/x weighted least squares. LODs for the 
CWA hydrolysis products were determined by multiplying the standard error of the y-
intercept by 3.3 and dividing by the slope of the curve; for positive ion mode, some of these 
calculated LODs were lower than the lowest-detected calibration samples, in which case 
the concentration of the first reliably detected calibration level was reported as the LOD. 
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Results and Discussion 
 The CWA hydrolysis products can be detected in positive ion mode as both 
protonated and sodiated ions, but they also form intense [M-H]- ions in negative ion mode 
because they all contain an acidic phosphonic acid moiety, so the quantitative performance 
of the five organophosphonate compounds in both positive and negative ion modes was 
compared. Using positive ionization with the optimized solvent system as determined with 
the intact CWA simulants61—95:5:0.01 methanol:water:formic acid—calibration curves 
could be generated in both blood and urine matrices, which are shown in Figure 20. 
Detection limits, relative errors in the slope, and correlation coefficients obtained from the 
ten calibration curves are shown in Table 5. 
Table 5. Comparison of quantitative capabilities of positive and negative ionization in the detection of CWA 
hydrolysis products in blood and urine matrices. 
 
______Positive Ion Mode______ ______Negative Ion Mode______ 
LOD 
[ng/mL] 
Rel. error in 
slope [%] 
R2 
LOD 
[ng/mL] 
Rel. error in 
slope [%] 
R2 
Blood       
EMPA 3 2 0.99 1.2 2 0.994 
IMPA 10 26 0.46 0.9 2 0.997 
iBuMPA 10 12 0.90 0.9 1 0.996 
CHMPA 10 7 0.97 0.8 1 0.998 
PinMPA 25 3 0.98 0.5 1 0.995 
       
Urine       
EMPA 0.7 1 0.99 1.2 3 0.982 
IMPA 6 10 0.72 1.2 2 0.994 
iBuMPA 3 8 0.84 1.1 2 0.996 
CHMPA 3 5 0.98 0.6 1 0.999 
PinMPA 6 4 0.97 0.4 1 0.998 
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Figure 20. Positive ion calibration curves for EMPA, IMPA, iBuMPA, CHMPA, and PinMPA in both blood 
(a-e) and urine (f-j) matrices. Each data point is the average of three replicates. 
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 Overall, detection of the CWA hydrolysis products as positive ions was 
complicated by their poor fragmentation in MS/MS mode. Despite good intensities for the 
positive molecular ions, the signal strength of their corresponding fragment ions was 
typically 10-100× lower than their negative ion counterparts, making quantitative analysis 
for positive ionization generally less sensitive. Furthermore, fragmentation for some of the 
hydrolysis products in positive ion mode was found to be unreliable, resulting in poor 
precision of analyte/ISTD measurements, as demonstrated for IMPA in Figure 21a. 
 
Figure 21. (a) Positive and (b) negative ion calibration curves for IMPA in blood, showing each individual 
analyte/ISTD measurement against its known concentration. 
 When operating in negative ion mode, however, [M-H]- molecular ions formed 
readily and fragmentation by high-energy collisional dissociation (HCD) in the q-orbitrap 
was efficient. By utilizing the optimized solvent from chapter 2—90:10:0.01 
methanol:CCl4:NH4OH—discharge could reliably be circumvented, allowing for greater 
precision of measurements and better quantitation. The negative ion calibration curves 
generated for EMPA, IMPA, iBuMPA, CHMPA, and PinMPA in blood and urine matrices 
are shown in Figure 22, with the quantitative measures summarized in Table 5 next to those 
obtained when spraying in positive ion mode. 
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Figure 22. Negative ion calibration curves for EMPA, IMPA, iBuMPA, CHMPA, and PinMPA in both blood 
(a-e) and urine (f-j) matrices. Each data point is the average of three replicates. 
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 In general, detection limits in negative ion mode improved with increasing analyte 
weight, achieving sub-ng/mL LODs for most compounds—down to 0.55 ng/mL in blood 
and 0.36 ng/mL in urine for PinMPA, respectively 50- and 15-fold improvements over its 
detection in positive ion mode. These LODs lie below the range measured from real victims 
of sarin exposure, where IMPA was present at concentrations between 2-135 ng/mL.67 The 
hydrolysis products demonstrated better quantitation overall when moving from positive 
ionization to negative ionization. IMPA and iBuMPA especially showed marked 
improvement in linearity of the calibration curve and sample- to-sample precision, 
exemplified by IMPA in Figure 21. EMPA showed comparable quantitation between 
positive and negative ion modes for blood and urine (Table 5). Furthermore, the resolving 
power of the orbitrap mass analyzer was capable of significantly reducing matrix 
interference as a potential problem for these analytes; blank biofluid showed no signal 
within the 5-ppm m/z window for the fragment ions. 
Conclusion 
 The PS-MS analysis of five CWA hydrolysis products—EMPA, IMPA, iBuMPA, 
CHMPA, and PinMPA—was capably demonstrated using both positive and negative 
ionization. Their detection in positive ion mode is useful because the intact CWAs 
generally ionize better under positive polarities, but analyzing them in negative ion mode 
afforded higher sensitivities and more linear calibration curves. LODs down to 0.4-1.2 
ng/mL—corresponding to absolute quantities between 5-15 pg—were achieved with 
negative ionization. Since concentrations were able to be detected from biological samples 
that were lower than those in real exposure victims, it shows promise for this as a direct 
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method of screening for nerve agent exposure, which could be vital in providing immediate 
medical attention and treatment in a first-responder scenario. 
 MS-based techniques are highly regarded in terms of specificity and sensitivity, but 
they traditionally require significant sample handling and processing procedures typically 
in a “brick and mortar” laboratory. Furthermore, most MS detection techniques, especially 
if they required extensive processing, could take as long as 24 hours to get interpretable 
results. Using PS-MS, quantitative results can be obtained in as little as one minute. This 
technology and approach could have immediate utility since analytical grade mass 
spectrometers such as the orbitrap are currently used in field-forward, portable laboratories 
such as the US Army’s JUPITR program.
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CHAPTER 4. APPLYING A PS-MS/MS DRUG SCREEN TO 
POSTMORTEM BLOOD SAMPLES 
Introduction 
High-Resolution Mass Spectrometry 
 Almost all of the data presented herein were acquired on a mass spectrometer with 
an orbitrap mass analyzer. When combined with tandem mass spectrometric analysis, this 
instrument is capable of providing excellent selectivity for compound identification. An 
orbitrap is a type of ion trap—based on a simpler model proposed by Kingdon in which 
ions were trapped in orbit around a central filament electrode98—that provides a means of 
obtaining high-resolution mass spectra by measuring ions’ exact masses.99,100 Such high 
mass accuracy can often signify a single molecular formula with a good degree of 
reliability, identifying the elemental composition of any given MS signal. 
 Instruments that are capable of measuring m/z with a high degree of accuracy—
typically on the ppm level—encompass a field that is appropriately known as high-
resolution MS (HR-MS). There are three major types of mass analyzing techniques that 
can accomplish such high-resolution measurements: orbital trapping (orbitrap), Fourier 
transform ion cyclotron resonance (FT-ICR),101,102 and time-of-flight (TOF).103 As they 
were not implemented in any of these studies, the mechanisms behind FT-ICR-MS and 
TOF-MS will only be mentioned in brief. 
 Geometrically, orbitraps consist of two coaxial electrodes, one of which is spindle-
shaped and surrounded by the other, which is shaped like a barrel (see Figure 23). When a 
potential difference is applied between these electrodes, injected ions that tangentially 
approach the central electrode begin to orbit it due to electrostatically attractive forces. 
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While maintaining these orbits, the ions also oscillate harmonically along the principal 
axis; the frequency of these axial oscillations is independent of the initial energy and 
position of the ions, but it is inversely proportional to the square root of the m/z of each 
ion.100 As they pass back and forth along the axis with their given frequencies of oscillation, 
the ions produce an image current on the outer electrode which is detected and transformed 
using fast Fourier algorithms to generate a high-resolution mass spectrum. Similar Fourier 
transform techniques can be applied to induced oscillations in standard quadrupole ion trap 
mass analyzers, but they do not achieve as high of a resolution as orbitraps.104,105 
 FT-ICR-MS utilizes the induced circular motion of moving ions in a static magnetic 
field, excited to larger and more measurable radii by electric fields, to generate its high-
resolution mass spectra.106 Similar to how detection in the orbitrap works, the ions rotate 
with a frequency that produces an image current on opposing electrodes in the system, 
which is then processed via fast Fourier transformations. TOF-MS, on the other hand, 
operates on the principles of kinematics, measuring the flight times of ions accelerated 
through a fixed-distance drift space. While not a source of great resolution in and of itself, 
the advent of the reflectron107 and eventually multipass instrumentation108,109 increased ion 
drift lengths and flight times while maintaining coherence of the traveling ion pulses. When 
paired with orthogonal acceleration from a continuous source of ions,110,111 TOF mass 
spectrometers can attain sufficiently high resolutions for exact-mass measurements. 
 Of the three mass analyzers, orbitraps typically fall in the middle in terms of 
resolving potential, achieving resolutions ~5× above TOF but ~10× below FT-ICR.112 By 
drastically extending drift lengths and flight times in TOF-MS, resolutions can be 
generated in excess of those normally attainable with orbitraps;108 however, the resolving 
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power necessary for identifying small molecules without error is around the limit of most 
TOF instruments.113 It should also be noted that, compared to orbital trapping, TOF mass 
analysis experiences less resolution decay with increasing m/z, so its mass-discriminating 
advantages lie with larger molecules rather than smaller ones. FT-ICR-MS can routinely 
achieve ppb-level exact-mass measurements,114,115 but the instrumentation required to 
supply the magnetic field is more demanding mechanistically and economically than most 
other mass spectrometers. As such, orbitraps provide a simpler means of accomplishing 
sufficient mass accuracy, especially for the small molecules presented throughout this 
work. 
 Comparisons of mass resolving power aside, HR-MS techniques in general offer 
several other advantages. One of those is the multiplex advantage, which arises from their 
ability to scan all ion masses simultaneously rather than having to scan over each mass 
individually.116 Because of this, full mass spectra are acquired instead of singly monitored 
ions, enabling retrospective analyses for target compounds which may have been 
unoptimized or even unidentified at the time of acquisition.117-119 Another advantage of 
HR-MS instrumentation is the capability of running data-dependent acquisitions.120,121 
Instrument methods can be set up such that if any mass is detected above a given limit, it 
is selected for fragmentation and analysis via full-scan MS/MS. These benefits, on top of 
the already-selective exact-mass measurements provided, have aided the implementation 
of HR-MS for both targeted and non-targeted screening.112,122 
Drug Screening 
 Both clinical and forensic toxicology rely on the accurate detection of drugs—
pharmaceutical or otherwise—within a person’s body. While the former suggests 
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physiological implications and is frequently used in therapeutic drug monitoring for 
medical treatments, the latter has potential legal implications and can mean the difference 
between determining a person’s innocence or guilt in a crime. To complicate matters 
further, the sheer number of evidentiary biological samples that pass through the legal 
system necessitates the use of large-panel drug screens that target many drugs 
simultaneously. While not completely comprehensive in the absolute sense, most screens 
used today employ analytical techniques to separate, identify, and even quantitate drugs 
from their native samples. For example, one screening method utilizes LC-TOF-MS to scan 
for 124 doping agents in urine samples within the span of 30 minutes.123 Newly developing 
methods strongly trend toward simpler and more efficient testing while still maintaining a 
high standard of analytical robustness. 
 Because it utilizes small amounts of sample, involves little-to-no sample 
preparation, and can produce reviewable results within minutes, PS-MS lends itself well to 
screening techniques. And considering the fact that much of the foundation of PS was built 
on the analysis and detection of small molecules such as drugs,10,11,24-26 this ambient 
ionization technique is a promising candidate for drug screening using MS. The main issue 
with using it for such purposes, however, is that it does not include an analytical separation, 
the closest analog being the rough extraction performed by the solvent when it passes 
through the sample. MS/MS can be used to make up for this selectivity loss, but large-
panel screens run into problems when other extracted matrix components are detected in 
addition to the target analytes. 
 Low-resolution triple quadrupole mass spectrometers can be used for PS-MS/MS 
drug screens by monitoring two separate fragment ions as well as their relative 
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abundance.33,34 However, because of the low mass accuracy they provide—identifying ions 
within a ±0.5 m/z ratio range, otherwise known as unit resolution—such instruments 
occasionally experience substantial background noise over the analytical signal, impacting 
the selectivity of MS/MS and worsening the overall performance of the screen. On the 
other hand, the mass accuracy provided by orbitraps—typically measuring m/z down to 
±0.0005 units—decreases this selectivity problem while still maintaining comparable 
sensitivity. Although they are more expensive than triple quadrupole instruments and 
require daily mass calibration, this advantage can play a critical role in improving the 
performance of PS-based screens. 
 The Q-Exactive series of mass spectrometers from Thermo Fisher Scientific used 
throughout this work utilizes a hybrid quadrupole-orbitrap design, which is detailed in 
Figure 23. The S-lens, flatapoles, and octopole primarily serve the purpose of ion optics, 
focusing the ion beam introduced into the system and conveying it through the 
differentially pumped sections of the instrument. Because of the nature of their operation, 
orbitraps cannot accept a continuous stream of ions into their space. It is for this reason 
that curved linear traps (C-traps) must be employed when using continuous ionization 
techniques such as ESI and PS; the C-trap accumulates ions as they pass through the 
instrument and then injects them orthogonally into the orbitrap in discrete packets, or 
pulses, for analysis.124,125 
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Figure 23. Schematic diagram of a Q-Exactive mass spectrometer from Thermo Fisher Scientific, which 
utilizes a hybrid quadrupole-orbitrap to achieve high mass resolution. 
 While HR-MS scans of intact ions have been shown to be as effective as MS/MS 
scans in lower-resolution instruments,126 the inclusion of a quadrupole gives the Q-
Exactive a greater degree of versatility. Through this quadrupole, precursor ions can be 
filtered by mass for either selected ion monitoring (SIM) or fragmentation in the HCD cell 
with subsequent MS/MS analysis. Because MS/MS itself is already powerful in selectively 
detecting target compounds, coupling it with high mass-discriminating capabilities often 
results in no background signal whatsoever at the observed fragment ion(s). Overall, this 
quadrupole-orbitrap hybridity with MS/MS methodology helps to provide the selectivity 
that PS-MS inherently lacks due to it not being a chromatographic technique, thereby 
increasing its potential effectiveness as a technique for simple and rapid drug screening. 
 A PS-MS/MS screening method has already been developed for 137 drugs with 11 
SIL ISTDs for quantitation, and initial work into it was performed on a triple quadrupole 
mass spectrometer.33,34 The goal of the following work was to adapt this PS-based screen 
to a quadrupole-orbitrap mass spectrometer and test the method on samples which are 
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routinely collected in death investigations: unknown, postmortem blood samples. After 
their analysis with PS, the results were compared to those of a more established screening 
method to evaluate the qualitative and quantitative performance of the PS-MS/MS screen. 
Materials and Methods 
Chemical Materials 
 Glacial acetic acid and HPLC-grade methanol, acetonitrile, isopropanol, and 
acetone were all purchased from Fisher Scientific (Pittsburgh, PA, USA). The human 
whole blood used in preparing the calibration samples was provided by a single donor. 30 
different postmortem (PM) blood samples—to be analyzed as unknowns in the drug 
screen—were received from Axis Forensic Toxicology (Indianapolis, IN, USA). Most of 
the 137 drugs and 11 SIL ISTDs used in the drug screen were purchased as analytical 
standards from Cerilliant (Round Rock, TX, USA) at concentrations of either 1.0 mg/mL 
or 100 μg/mL in methanol. Acetaminophen, amlodipine, aripiprazole, benztropine, 
bupivacaine, carbamazepine, donepezil, etomidate, fluvoxamine, hydroxyzine, labetalol, 
metaxalone, methocarbamol, metoclopramide, papaverine, and ropinirole were all 
purchased as powders from Sigma Aldrich (St. Louis, MO, USA) and dissolved in 95:5 
methanol:water to create standard solutions. 
Sample Preparation 
 The 137 analytes were first divided up into 16 separate groups to maintain low 
organic content in the blood samples and to prevent structural isomers from interfering 
with individual analyses when generating the calibration curves. For most of these groups, 
spiking solutions were created by diluting the analyte standards to 1000× their screening 
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cutoff in 50:50 methanol:water, which were then diluted in the same matrix according to 
the series 2:5, 1:2, 2:5, and 1:4; each of these spiking solutions was then diluted 1:20 in 
blood to generate the calibrant samples. Six of the sixteen mixtures had to be prepared 
directly in the biological matrix, for which the analyte standards were spiked into blood to 
generate concentrations either 250× or 500× the screening cutoff, followed by serial 
dilution using the same series of 2:5, 1:2, 2:5, and 1:4. 
 All calibrant and PM samples were mixed 1:3 (v:v) with an aqueous ISTD mixture 
before spotting. The concentrations of each ISTD in this mixture were: 65 ng/mL of 
alprazolam-d5 (A); 650 ng/mL of benzoylecgonine-d8 (B), cocaine-d3 (C), and 
methamphetamine-d11 (I); 260 ng/mL of flunitrazepam-d7 (D), hydrocodone-d3 (F), and 
trimipramine-d3 (J); 1300 ng/mL of gabapentin-d10 (E); 2600 ng/mL of metaxalone-d6 
(G); 325 ng/mL of methadone-d3 (H); and 130 ng/mL of zolpidem-d6 (K). For ease of 
reporting, the ISTDs—in alphabetical order—were given labels A-K. 
Paper Spray Ionization 
 Paper spray was achieved using VSCs on the automated Velox 360 source from 
Prosolia (Indianapolis, IN, USA); 12 μL of sample were spotted on the cartridges and 
allowed to dry at room temperature before spraying. The spray solvent used was 
85:10:5:0.01 acetonitrile:acetone:water:acetic acid. In total, 136 μL of solvent were 
gradually applied to each cartridge—6 μL directly onto the DBS via pump A and 130 μL 
into the solvent well via pump B—over the course of 2.43 minutes. 
Mass Spectrometry 
 All data were acquired on a Q-Exactive Focus orbitrap mass spectrometer (Thermo 
Fisher Scientific, San Jose, CA, USA) with the S-lens set to 75 and capillary temperature 
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set to 320°C. The instrument method was 2.43 minutes long, operating in positive ion mode 
at +5.0 kV for the first 1.6 min before turning the voltage off to 0 kV for the next 0.83 min. 
In the final 0.2 min, the instrument was switched to negative ionization at -4.0 kV to 
prevent charge buildup on the S-lens. The voltage was turned off for 0.83 min at the end 
of the run to generate zero-intensity scans for each drug, which were required for automated 
data processing in Thermo’s TraceFinder. 
 The mass spectrometer was operated solely in MS/MS mode using an inclusion list 
with an isolation width of ±0.5 m/z in the first quadrupole to filter precursor ions; a 
maximum injection time of 50 ms was used to accommodate the number of scans required 
for reliable signal detection across all compounds in the method. In the event where the 
precursor ions of two or more drugs were close enough in mass to have both passed through 
the first quadrupole and into the orbitrap mass analyzer, a single scan event was used for 
both and the same CE was used for fragmentation. The precursor ions, fragment ions, and 
optimized CEs for all 137 drugs and the 11 SIL ISTDs can be found in Table 6. For 
norpropoxyphene, norsertraline, and propoxyphene, the precursor ions fragmented within 
the first quadrupole, and since these primary fragment ions demonstrated higher signal than 
the precursors in full-MS mode, they were selected for further fragmentation via MS/MS. 
Table 6. Fragmentation of each analyte and SIL ISTD used in the PS-MS/MS drug screen. The fragment ion 
indicated was the primary fragment ion used for quantitation. 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
6-Monoacetylmorphine 328.1543 211.0753 25 
7-Aminoclonazepam 286.1000 121.0760 30 
7-Aminoflunitrazepam 284.1194 135.0915 30 
9-Hydroxyrisperidone 427.2140 207.1127 33 
Acetaminophen 152.0706 110.0602 20 
Alfentanil 417.2609 268.1763 20 
Alpha-PVP 232.1696 126.1276 22 
Alprazolam 309.0902 281.0712 45 
Amitriptyline 278.2000 191.0852 28 
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Table 6 (continued) 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
Amlodipine 409.1525 238.0625 15 
Amphetamine 136.1121 119.0858 10 
Aripiprazole 448.1553 285.0910 30 
Atenolol 267.1700 145.0646 26 
Baclofen 214.0629 116.0620 32 
Benzoylecgonine 290.1387 168.1015 20 
Benztropine 308.1850 167.0850 35 
Benzylpiperazine 177.1386 91.0546 20 
Brompheniramine 319.1400 274.0215 20 
Bupivacaine 289.1000 140.1430 33 
Buprenorphine 468.3108 414.2630 42 
Bupropion 240.1150 131.0728 30 
Buspirone 386.2551 122.0710 35 
Carbamazepine 237.1022 194.0961 26 
Carbamazepine-10,11-epoxide 253.0972 180.0806 24 
Carisoprodol 283.1628 200.1644 16 
Chlordiazepoxide 300.1000 227.0489 21 
Chlorpheniramine 275.1000 230.0726 19 
Chlorpromazine 319.1030 197.1361 30 
Citalopram 325.1711 109.0449 24 
Clomipramine 315.1623 86.0969 50 
Clonazepam 316.0484 214.0416 45 
Clozapine 327.1371 270.0786 25 
Cocaethylene 318.1700 196.1328 25 
Cocaine 304.1543 182.1170 30 
Codeine 300.1594 215.1064 30 
Cyclobenzaprine 276.1747 215.0853 60 
Demoxepam 287.0582 219.1569 23 
Desalkylflurazepam 289.1000 140.0260 33 
Desipramine 267.1700 72.0813 26 
Dextromethorphan 272.2009 147.0801 32 
Diazepam 285.1000 154.0415 33 
Diltiazem 415.1686 178.0315 23 
Diphenhydramine 256.1000 167.0851 25 
Donepezil 380.2220 243.1373 28 
Doxepin 280.1696 107.0493 25 
Doxylamine 271.1805 182.0962 18 
Duloxetine 298.1260 267.0836 15 
EDDP 278.1903 234.1271 38 
Ephedrine/Pseudoephedrine 166.1226 115.0544 26 
Etomidate 245.1285 113.0346 30 
Felbamate 239.1026 117.0702 10 
Fentanyl 337.2274 188.1431 25 
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Table 6 (continued) 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
Flecainide 415.1451 301.0284 46 
Flunitrazepam 314.0936 239.0975 40 
Fluoxetine 310.1413 168.0890 35 
Flurazepam 388.1586 315.0685 28 
Fluvoxamine 319.1400 71.0497 20 
Gabapentin 172.1332 137.0959 17 
Haloperidol 376.1474 123.0242 55 
Hydrocodone 300.1594 199.0752 30 
Hydromorphone 286.1000 185.0594 30 
Hydroxychloroquine 336.1837 179.0370 20 
Hydroxyzine 375.1834 201.0461 20 
Ketamine 238.0993 125.0152 20 
Labetalol 329.1860 162.0545 25 
Lamotrigine 256.1000 210.9821 25 
Levetiracetam 171.1128 126.0914 20 
Lidocaine 235.1805 86.0967 20 
Lorazepam 321.0192 275.0129 32 
MDA 180.1019 133.0647 15 
MDMA 194.1176 135.0438 25 
MDPV 276.1594 126.1276 27 
Meperidine 248.1645 174.1274 20 
Mephedrone 178.1226 145.0883 25 
Meprobamate 219.1100 162.0915 12 
Mescaline 212.1281 180.0780 20 
Metaxalone 222.1125 161.0960 10 
Methadone 310.2165 265.1580 18 
Methamphetamine 150.1277 91.0546 10 
Methocarbamol 242.1023 118.0500 10 
Methylone 208.0968 160.0754 20 
Methylphenidate 234.1489 84.0811 20 
Metoclopramide 300.1000 227.0575 21 
Metoprolol 268.1907 116.1070 20 
Midazolam 326.0855 244.0320 30 
Mirtazapine 266.1500 195.0914 24 
Morphine 286.1000 201.0905 30 
Naproxen 231.1016 185.0963 20 
Norbuprenorphine 414.2639 83.0861 60 
Norclomipramine 301.1466 72.0813 20 
Norclozapine 313.1300 270.0783 26 
Nordiazepam 271.0633 140.0259 34 
Nordoxepin 266.1500 107.0493 24 
Norfluoxetine 296.1257 100.1124 20 
Norketamine 224.0837 125.0151 15 
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Table 6 (continued) 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
Normeperidine 234.1489 160.1118 15 
Norpropoxyphene (fragment) 308.2009 143.0856 25 
Norsertraline (fragment) 275.1000 158.9759 19 
Nortramadol 250.1802 189.1274 15 
Nortriptyline 264.1800 191.0853 28 
Norvenlafaxine 264.1800 107.0494 28 
o-/m-Chlorophenylpiperazine 197.0840 154.0416 26 
Olanzapine 313.1300 256.0893 26 
Oxazepam 287.0582 241.0521 23 
Oxycodone 316.1543 241.1089 33 
Oxymorphone 302.1387 227.0934 35 
Papaverine 340.1543 202.0858 28 
Paroxetine 330.1500 192.1179 22 
PCP 244.2060 159.1166 13 
Pentazocine 286.2165 218.1535 20 
Phenytoin 253.0972 182.0965 24 
Pregabalin 160.1332 124.1118 12 
Primidone 219.1100 162.0912 12 
Promethazine 285.1000 198.0369 33 
Propoxyphene (fragment) 266.1500 143.0854 24 
Propranolol 260.1645 116.1070 20 
Quetiapine 384.1740 253.0795 25 
Ranitidine 315.1485 176.0484 18 
Risperidone 411.2191 191.1172 35 
Ropinirole 261.1961 114.1277 24 
Sertraline 306.1000 158.9760 29 
Sildenafil 475.2122 283.1183 45 
Temazepam 301.0738 255.0677 36 
TFMPP 231.1104 188.0679 32 
Topiramate 362.0880 265.1047 18 
Tramadol 264.1958 58.0659 10 
Trazodone 372.1586 176.0814 25 
Triazolam 343.0512 315.0318 35 
Trimipramine 295.2169 100.1123 25 
Vardenafil 489.2279 169.0968 50 
Venlafaxine 278.2000 121.0648 28 
Verapamil 455.2904 165.0906 30 
Zaleplon 306.1000 236.0927 29 
Ziprasidone 413.1197 194.0362 30 
Zolpidem 308.1850 235.1224 35 
Zonisamide 213.0328 150.0548 22 
Zopiclone 389.1123 217.0270 40 
Alprazolam-d5 A 314.1215 314.1215 45 
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Table 6 (continued) 
Compound 
Precursor Ion 
[m/z] 
Fragment Ion 
[m/z] 
CE 
[V] 
Benzoylecgonine-d8 B 298.2000 171.1208 25 
Cocaine-d3 C 307.1732 307.0732 30 
Flunitrazepam-d7 D 321.1375 321.1375 40 
Gabapentin-d10 E 182.1960 182.1960 17 
Hydrocodone-d3 F 303.1783 303.1783 30 
Metaxalone-d6 G 228.1501 228.1501 10 
Methadone-d3 H 313.2354 313.2354 18 
Methamphetamine-d11 I 161.1968 161.1968 10 
Trimipramine-d3 J 298.2000 298.2357 25 
Zolpidem-d6 K 314.2134 314.2134 35 
 
Data Processing 
 All data were automatically processed using TraceFinder v. 3.3 (Thermo Fisher 
Scientific). Peaks within a 5-ppm window of the target compound’s fragment ion were 
integrated. The analyte peak area was then divided by the area of the corresponding 
fragment ion of the appropriate ISTD. Each calibration point was run in duplicate and the 
ratios of analyte signal to ISTD signal were plotted against their known concentrations to 
generate the calibration curve, which was linearly fit using 1/x weighted least squares. 
Limits of reporting (LORs) were determined by the lowest reliably detected calibrator 
above noise. 
Postmortem Sample Drug Screen 
 All 30 unknown PM samples were run in triplicate alongside the calibration 
samples, and each analyte/ISTD measurement was plotted on the corresponding calibration 
curve to semi-quantitatively determine the amount of drug present. The results of this PS-
MS/MS drug screen were then compared to those of a more established screening method 
using HPLC-MS, which was run off-site and independently by Axis Forensic Toxicology. 
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Results and Discussion 
Paper Spray Screening on a Quadrupole-Orbitrap Mass Spectrometer 
 When screening for a relatively large number of targets using an MS/MS inclusion 
list, the settings of the mass spectrometer must be adjusted to ensure an adequate number 
of scans are obtained for each target within the time the cartridge is spraying; in this screen, 
5 scans per target was chosen as a standard for achieving accurate m/z measurements and 
ion ratios as well as acceptable quantitative performance. When using a single VSC with 
the Velox 360 PS source, though, spraying times are limited by the amount of applied spray 
solvent, which is in turn limited by the volume that can be retained by the paper tip and in 
the solvent well. Since it is not currently possible to apply solvent during an acquisition on 
the automated source, the finite amount applied to the cartridge beforehand limits the 
length of the spraying process to about 90 seconds, so an injection time of 50 ms was 
accordingly used to allow for the collection of the 5 scans for each target. 
 An example of the total ion chronogram acquired using the described instrument 
method is shown in Figure 24a, where each stick is an individual MS/MS scan. A full cycle 
of these scans, encompassing all target compounds, completed within ~0.3 minutes. 5 or 6 
scans were acquired for each MS/MS scan filter followed by a zero-intensity scan at the 
end, which was obtained by turning off the spray voltage 1.6 minutes into the acquisition. 
Such zero-scans were necessary for automatic peak integration through the TraceFinder 
software. The extracted ion chronogram for cocaine—the filter for which fragmented 
precursor ions at m/z 304.1543 ±0.5—is shown in Figure 24b, demonstrating the number 
and frequency of MS/MS scans as well as the zero-scan. 
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Figure 24. (a) Total ion chronogram (all scans combined). (b) Extracted ion chronogram from MS/MS scans 
of cocaine. (c) Tandem mass spectrum for a neat standard of cocaine at 200 ng/mL, infused via commercial 
ESI. (d) Tandem mass spectrum for blood spiked with 16 ng/mL cocaine (0.33× its cutoff), sprayed via paper 
spray. 
 The injection time is an instrument parameter analogous to dwell time in triple 
quadrupole mass spectrometers, and as such it affects the amount of signal detected; using 
larger injection times, for example, improves sensitivity by allowing more ions into the 
orbitrap and more completely filling it. For all but six of the drugs screened here, detection 
at the cutoff was sufficient with an injection time of 50 ms, and increasing it allowed for 
better detection of the six that failed at their cutoff. However, since 5-6 scans were desired, 
attempting to increase the injection time would lead to a total acquisition time of around 5-
6 minutes, which would not be possible with paper spray unless spray solvent could be 
continuously applied to the cartridge. 
 On top of sensitivity, selectivity is another concern of any screening technique. As 
stated before and can be seen in Figure 24d for the MS/MS spectrum of cocaine, analytes 
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can be confidently detected straight from blood samples—even at concentrations below the 
screening cutoff—owing to the high mass accuracy provided by the orbitrap mass analyzer. 
And while the biomatrix generates extraneous peaks not seen in neat matrices (Figure 24c), 
the selectivity provided by the exact-mass measurements was enough to identify the 
prominent peaks at m/z 182.117 and below as indicative of the presence of cocaine. 
 The instrument resolution used here was 35,000, which lies in the middle of the 
range offered by the instrument; to avoid increasing the scan times and worsening any 
sensitivity problems, the highest resolution was not used. Together with the 5-ppm 
detection window used in data processing, the selectivity afforded by the instrument was 
sufficient for all targets, making sensitivity the primary limiting factor, and even then only 
for those drugs whose signal at the cutoff was genuinely not high enough for detection. 
 Almost all drugs screened saw the production of more than one fragment ion. In 
such cases, the weaker ions could be used as confirmatory ions for positive detection, 
bolstering specificity, while the strongest ion would be used for quantitation 
measurements; in this study, however, only the strongest ion was utilized for both purposes 
of identification and quantitation. 
 For more non-exhaustive screens, where the number of target compounds is few in 
comparison, the determination of instrumental parameters is more flexible and can be 
readily altered to improve detection. But for the 148-target (including ISTDs) screen 
employed here—spread out over 130 unique MS/MS scan events—these parameters were 
set to strike a balance between sensitivity and selectivity, all within the short sampling 
period supported by paper spray. As such, further improvement of the screen could not be 
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accomplished solely by altering instrument-side variables, but rather had to be done 
chemically by altering the method itself, which mostly consisted of the spray solvent used. 
Method Optimization for Postmortem Samples 
 Previous work into developing this positive ion PS-MS/MS drug screen saw the 
spiking of 10 μL of the ISTD mixture into 200 μL of each sample as well as the utilization 
of 95:5:0.01 methanol:water:acetic acid as the spray solvent, operated at an onset voltage 
of 4.0 kV. However, this method had only been used in the generation of analyte calibration 
curves and had not been tested with any of the PM blood samples. When making the 
transition from a single living blood donor to multiple deceased blood donors—coupled 
with differing levels of coagulation—matrix effects started to become more noticeable. As 
can be seen in Figure 25, the measured ISTD MS/MS signal from the PM samples was 
typically weaker than the calibrant samples, showing inconsistency between the unknowns 
themselves as well as the samples used in generating the calibration curves, which would 
impede the accuracy of any attempted quantitation. Of the ISTDs, metaxalone-d6 suffered 
the most from the effects of these diverse chemical backgrounds, remaining completely 
undetected in over half of the PM samples. To address this problem, new methods were 
investigated to mitigate the ion suppressing effects of the different matrices by increasing 
ISTD sensitivity and achieving consistent signal strength between the PM and calibrant 
samples. 
 Acetonitrile was tested as an alternative organic phase in the spray solvent. Previous 
work127 demonstrated that acetonitrile-based solvents show lower ion suppression than 
methanol solvents, presumably because of lower solubility of salts and lipids. However, 
the use of acetonitrile-water mixtures is problematic as they are less capable than methanol-
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water mixtures in permeating and fully wetting DBSs, which completely stymies the 
spraying process. Isopropanol and acetone were both investigated as cosolvents to increase 
the ability of the spray solvent to penetrate the DBS; to the same end, thinning the blood 
samples—either by mixing them 1:1 (v:v) with 0.9% saline solution before spiking in the 
ISTD or by mixing them up to 1:9 (v:v) directly with the aqueous ISTD mixture—before 
spotting was also tested. Of these different sample preparation and spray solvent 
combinations, spraying with 85:10:5:0.01 acetonitrile:acetone:water:acetic acid at a 5.0 kV 
onset voltage allowed for proper and consistent spraying across multiple different samples, 
but only if the blood samples had been mixed 1:3 (v:v) with an aqueous ISTD mixture 
before spotting. 
 The results of this new method tested against the original method are demonstrated 
through the raw ISTD MS/MS signals shown in Figure 25 and summarized in Table 7. 
When using the new method, there were no issues with the detection of any ISTDs from 
any of the PM samples, and almost all of them experienced a notable increase in sensitivity 
over the original method. Furthermore, the signal achieved using the new method was 
much more stable and comparable across the different PM and calibrant samples. These 
facts taken together indicate that the new method of sample preparation as well as the new 
solvent would allow for more reliable quantitative conclusions to be drawn regarding 
analyte detection in the PM samples. 
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Table 7. Raw ISTD MS/MS signal in the PM and calibrant samples when sprayed using the new method 
(85:10:5:0.01 acetonitrile:acetone:water:acetic acid with thinned blood samples) as compared to the original 
method (95:5:0.01 methanol:water:acetic acid). 
ISTD 
____Original Method____ ______New Method______ 
PM Samples Calibrants PM Samples Calibrants 
Alprazolam-d5     
AUC 6.67×108 8.84×108 3.50×108 3.14×108 
RSD 38% 36% 46% 26% 
Benzoylecgonine-d8     
AUC 1.52×107 1.34×108 3.56×108 3.06×108 
RSD 48% 54% 28% 27% 
Cocaine-d3     
AUC 3.71×108 5.78×108 6.79×108 5.65×108 
RSD 28% 32% 28% 24% 
Flunitrazepam-d7     
AUC 3.72×105 1.38×106 4.00×107 2.30×107 
RSD 75% 38% 32% 27% 
Gabapentin-d10     
AUC 1.79×106 4.13×106 3.52×107 3.59×107 
RSD 80% 38% 42% 31% 
Hydrocodone-d3     
AUC 9.17×106 2.23×107 6.97×107 8.61×107 
RSD 45% 35% 30% 28% 
Metaxalone-d6     
AUC 5.05×104 5.62×106 2.41×107 2.96×107 
RSD 260% 94% 32% 24% 
Methadone-d3     
AUC 1.00×109 9.58×108 9.39×108 8.56×108 
RSD 38% 43% 50% 32% 
Methamphetamine-d11    
AUC 1.05×108 3.23×108 6.85×108 8.97×108 
RSD 54% 41% 38% 35% 
Trimipramine-d3     
AUC 2.21×108 4.13×108 6.19×108 5.82×108 
RSD 34% 33% 48% 27% 
Zolpidem-d6     
AUC 1.22×107 1.97×107 2.26×107 1.88×107 
RSD 28% 33% 29% 26% 
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Figure 25. MS/MS signals between the original (a-d) and new (e-h) methods of sample preparation and 
spraying for the ISTDs benzoylecgonine-d8, flunitrazepam-d7, gabapentin-d10, and metaxalone-d6. Average 
values for half of the PM samples, run in triplicate, are shown along with an average value for calibrants run 
alongside them, with the error bars indicating one standard deviation above and below these values. 
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Limits of Reporting 
 Using this new method, all samples were prepared in a similar fashion and run 
concurrently, spraying each calibrant sample in duplicate to generate the calibration curves 
used in quantitating the amount of each analyte detected in the PM samples, which were 
all run in triplicate. The calibration curves are summarized in Table 8 and the results of the 
drug screen are given in Table 9. 
 For most drugs, no signal was detected when blank matrix was sprayed, but some 
saw high blank signal. To calculate signal-to-blank ratios (S/B), the average analyte 
MS/MS signal at the LOR was divided by either the average blank signal or an estimate of 
the electrical noise produced by the mass spectrometer (~1×105)—whichever was higher. 
When combined with the results of the calibration curves, an estimate can be made as to 
which drugs could potentially be screened for at lower concentrations; for example, 
bupivacaine, carbamazepine, lidocaine, and papaverine all demonstrated such potential. 
Table 8. Quantitative measurements for each of the analyte calibration curves which ran concurrently with 
the PM samples in the PS-MS/MS drug screen. 
Analyte ISTD 
LOR 
[ng/mL] 
S/B at 
LOR 
Rel. Error in 
Slope [%] 
R2 
6-Monoacetylmorphine F 20 5 3 0.993 
7-Aminoclonazepam F 25 34 3 0.994 
7-Aminoflunitrazepam F 20 52 3 0.992 
9-Hydroxyrisperidone F 10 155 7 0.963 
Alfentanil K 50 257 7 0.961 
Alpha-PVP K 50 214 9 0.936 
Alprazolam A 5 3 2 0.996 
Amitriptyline J 20 72 3 0.994 
Amlodipine F 20 2 7 0.959 
Amphetamine I 80 3 5 0.984 
Aripiprazole H 50 111 8 0.951 
Atenolol F 100 48 3 0.993 
Benzoylecgonine B 50 7 1 0.998 
Benztropine H 10 303 6 0.972 
Benzylpiperazine F 50 2 2 0.997 
Brompheniramine H 25 83 13 0.877 
Bupivacaine H 250 4696 5 0.983 
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Table 8 (continued) 
Analyte ISTD 
LOR 
[ng/mL] 
S/B at 
LOR 
Rel. Error in 
Slope [%] 
R2 
Buprenorphine H 10 6 4 0.986 
Bupropion K 50 156 11 0.915 
Buspirone H 6 69 33 0.528 
Carbamazepine J 1000 5925 9 0.940 
Chlordiazepoxide K 50 120 5 0.981 
Chlorpheniramine H 15 145 5 0.977 
Chlorpromazine J 50 42 5 0.983 
Citalopram H 10 63 10 0.926 
Clomipramine J 20 35 3 0.993 
Clonazepam A 30 2 4 0.984 
Clozapine K 50 542 8 0.951 
Cocaethylene C 50 136 2 0.997 
Cocaine C 50 36 12 0.903 
Codeine F 20 7 3 0.992 
Cyclobenzaprine J 10 208 2 0.997 
Demoxepam D 50 58 5 0.980 
Desalkylflurazepam A 50 64 6 0.972 
Desipramine J 20 195 4 0.990 
Dextromethorphan H 10 78 8 0.952 
Diazepam A 50 97 3 0.995 
Diltiazem K 50 129 11 0.910 
Diphenhydramine H 25 7 4 0.986 
Donepezil H 45 47 4 0.989 
Doxepin J 20 128 5 0.977 
Doxylamine K 25 60 6 0.974 
Duloxetine H 400 1 10 0.963 
EDDP H 25 141 6 0.973 
Ephedrine/Pseudoephedrine I 50 17 2 0.996 
Etomidate A 100 9 5 0.982 
Fentanyl C 1 10 4 0.988 
Flecainide K 250 549 5 0.981 
Flunitrazepam D 20 5 4 0.989 
Fluoxetine H 20 3 3 0.992 
Flurazepam H 25 182 5 0.979 
Fluvoxamine K 15 7 9 0.933 
Gabapentin E 250 39 7 0.966 
Haloperidol H 10 264 7 0.963 
Hydrocodone F 20 35 2 0.998 
Hydromorphone F 20 11 6 0.973 
Hydroxychloroquine K 2000 336 12 0.899 
Hydroxyzine K 10 82 4 0.985 
Ketamine H 100 370 7 0.963 
Labetalol F 45 50 5 0.983 
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Table 8 (continued) 
Analyte ISTD 
LOR 
[ng/mL] 
S/B at 
LOR 
Rel. Error in 
Slope [%] 
R2 
Levetiracetam G 2000 3 4 0.984 
Lidocaine K 250 4303 3 0.993 
Lorazepam D 25 5 6 0.970 
MDA I 100 8 4 0.984 
MDMA I 45 79 3 0.994 
MDPV K 45 360 4 0.987 
Meperidine K 25 137 5 0.980 
Mephedrone I 45 64 5 0.983 
Meprobamate B 1000 3 11 0.910 
Mescaline F 100 3 6 0.971 
Metaxalone G 1000 37 7 0.966 
Methadone H 15 165 5 0.980 
Methamphetamine I 45 70 2 0.995 
Methylone I 45 17 5 0.983 
Methylphenidate K 20 464 2 0.997 
Metoclopramide F 100 726 5 0.982 
Metoprolol F 45 131 3 0.993 
Midazolam K 45 65 4 0.987 
Mirtazapine K 45 572 4 0.985 
Morphine F 30 3 5 0.980 
Naproxen B 14994 3 14 0.878 
Norbuprenorphine H 100 11 13 0.880 
Norclomipramine J 36 276 2 0.998 
Norclozapine J 45 140 3 0.993 
Nordiazepam A 50 133 5 0.978 
Nordoxepin J 20 65 4 0.985 
Norfluoxetine H 20 38 2 0.997 
Norketamine F 91 114 5 0.978 
Normeperidine F 25 297 6 0.972 
Norpropoxyphene (fragment) H 50 16 3 0.995 
Nortramadol K 1000 1 8 0.953 
Nortriptyline J 20 66 3 0.994 
Norvenlafaxine K 25 2 52 0.312 
o-/m-Chlorophenylpiperazine F 20 89 4 0.989 
Olanzapine K 50 164 7 0.966 
Oxazepam D 50 41 4 0.987 
Oxycodone F 50 18 3 0.992 
Oxymorphone F 15 5 5 0.981 
Papaverine K 250 2064 3 0.994 
Paroxetine K 15 57 7 0.959 
PCP H 25 1 12 0.901 
Pentazocine H 50 425 4 0.987 
Pregabalin E 250 7 7 0.958 
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Table 8 (continued) 
Analyte ISTD 
LOR 
[ng/mL] 
S/B at 
LOR 
Rel. Error in 
Slope [%] 
R2 
Primidone B 750 3 11 0.910 
Promethazine H 25 61 5 0.978 
Propoxyphene (fragment) H 50 39 3 0.994 
Propranolol K 50 194 2 0.996 
Quetiapine K 50 579 5 0.983 
Ranitidine F 250 231 5 0.981 
Risperidone K 10 48 7 0.961 
Ropinirole K 10 144 5 0.982 
Sertraline H 100 18 6 0.971 
Sildenafil F 100 14 3 0.994 
Temazepam D 50 86 2 0.997 
TFMPP K 50 386 3 0.992 
Tramadol K 100 8 3 0.991 
Trazodone K 100 539 3 0.995 
Triazolam A 20 19 5 0.982 
Trimipramine J 20 179 3 0.993 
Vardenafil F 100 39 4 0.989 
Venlafaxine F 50 3 4 0.984 
Verapamil H 50 267 4 0.987 
Zaleplon D 15 3 4 0.986 
Ziprasidone H 40 49 9 0.944 
Zolpidem K 10 169 1 0.999 
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Table 9. Results from the PS-MS/MS drug screen for each of the 30 PM samples. 
PM Sample Drug (Concentration [ng/mL]) 
#1 None detected 
#2 
7-Aminoclonazepam (95); benztropine (20); bupropion (308); 
fluoxetine (31); quetiapine (130); risperidone (15); tramadol (1346) 
#3 Hydrocodone (82); lidocaine (544) 
#4 Donepezil (84); gabapentin (781); nortramadol (987) 
#5 Hydrocodone (38); norbuprenorphine (21) 
#6 
Alprazolam (28); amlodipine (34); gabapentin (13679); hydrocodone 
(253); nordiazepam (106) 
#7 None detected 
#8 
Bupropion (366); chlorpheniramine (41); codeine (128); 
dextromethorphan (146); gabapentin (26882); hydrocodone (29); 
promethazine (37) 
#9 Gabapentin (14981); mirtazapine (176); sertraline (128) 
#10 None detected 
#11 Bupropion (253); diphenhydramine (67); gabapentin (4781) 
#12 Diazepam (154); metoclopramide (160); nordiazepam (194) 
#13 
Alprazolam (136); Nordiazepam (173); oxycodone (152); 
oxymorphone (57) 
#14 
6-Monoacetylmorphine (348); codeine (21); hydromorphone (88); 
morphine (937) 
#15 Diphenhydramine (160) 
#16 Cyclobenzaprine (59); EDDP (114); methadone (669) 
#17 None detected 
#18 None detected 
#19 Citalopram (580); gabapentin (1056) 
#20 
Amitriptyline (926); metoclopramide (254); morphine (217); naproxen 
(135781); nortriptyline (1894); paroxetine (796); pregabalin (1378) 
#21 9-Hydroxyrisperidone (46) 
#22 
Bupropion (97); buspirone (464); diazepam (247); gabapentin (33397); 
mirtazapine (141); nordiazepam (335); zolpidem (35) 
#23 None detected 
#24 Citalopram (462); hydrocodone (31) 
#25 Amphetamine (254) 
#26 
Alprazolam (34); doxepin (421); gabapentin (8358); methadone (362); 
nordoxepin (342) 
#27 
Alprazolam (35); benzoylecgonine (206); citalopram (763); 
hydroxyzine (362) 
#28 Diphenhydramine (97); doxylamine (73); hydrocodone (50) 
#29 None detected 
#30 Amphetamine (199); methamphetamine (5761); morphine (52) 
 
 For almost all drugs tested, the LOR given was the concentration in the lowest 
calibrant; as long as they lay above this LOR value and within the range of the calibration 
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curve, the calculated concentrations of such drugs in the PM samples were as reliable as 
the calibration itself. Duloxetine, norbuprenorphine, and nortramadol, though, were 
exceptions to this—their LORs were increased because the raw MS/MS signal provided by 
lower concentrations was not enough to distinguish it from the blank signal. This was 
important to bear in mind when interpreting the results of the drug screen on the PM 
samples. For example, nortramadol, the calibration curve of which spanned the range from 
250 ng/mL to 12500 ng/mL, was detected in one of the PM samples and quantitated at a 
concentration of 987 ng/mL. However, it was not able to be reliably discerned from blank 
signal in the calibrant samples until 1000 ng/mL, indicating that, despite the linearity of its 
calibration curve, all measurements below this value would be difficult to accurately 
quantitate. Similar detection concerns arise from the other two drugs whose LORs were 
increased. 
Evaluating the PS-MS/MS Drug Screen 
 Several general HPLC-MS drug screens were performed on PM samples from the 
same 30 donors to detect and quantitate the amount of each drug present. These results in 
addition to those presented in Table 9 were used as a basis for evaluating the integrity of 
the PS-MS/MS drug screen by monitoring the occurrence of true positives (TPs) and 
negatives (TNs) as well as, more importantly, false positives (FPs) and negatives (FNs). 
 Because of the superior selectivity afforded by using MS/MS coupled with the high 
resolution from the orbitrap mass analyzer, the background for many of the observed 
fragment ions was zero. (It was for this reason that 1×105 had to be used as an estimate of 
blank noise in the S/B measurements shown in Table 8.) Therefore, any reliably detected 
signal could be interpreted as originating from the analyte itself. In a few cases, such no-
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background targets were clearly detected in the PM samples, signifying the analyte’s 
presence, but their calculated concentrations were lower than the established LOR; these 
were accordingly not reported as quantitative results, but only as qualitatively detected 
drugs. This biased detection toward positive results (both TPs and FPs) was used to 
demonstrate the capability of the PS-MS/MS screen in detecting as many drugs as possible. 
 Of the 137 drugs screened for across each of the 30 PM samples—either passing 
(present) or failing (absent) detection—a total of 4110 qualitative and binary results were 
obtained. These results are summarized in Table 10 for both screening methods. PS-
MS/MS detected a total of 91 drugs across all samples, with 10 of them failing detection 
via the HPLC-MS screens (the FPs). 88 drugs were detected using HPLC, but 7 of them 
were not caught with the PS method (the FNs). In total, 4012 drugs were confirmed to be 
absent from the PM samples by both screening methods. 
Table 10. Qualitative results of the HPLC- and PS-based drug screens. 
Qualitative Result 
_______Detection Criteria_______ 
Frequency 
HPLC PS 
True Positive (TP) Positive Positive 81 
False Positive (FP) Negative Positive 10 
True Negative (TN) Negative Negative 4012 
False Negative (FN) Positive Negative 7 
 
 Qualitatively, the rates of occurrence for positive and negative results can be used 
in measuring a method’s sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV). These values are defined as:128 
 Sensitivity =
TP
TP + FN
∙ 100 = 92.0% (1) 
 Specificity =
TN
TN + FP
∙ 100 = 99.8% (2) 
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 PPV =
TP
TP + FP
∙ 100 = 89.0% (3) 
 NPV =
TN
TN + FN
∙ 100 = 99.8% (4) 
Put in context, qualitative sensitivity is a measure of how often the presence of a drug is 
accurately detected by the technique. Specificity is the opposite, measuring how often a 
drug’s absence is accurately indicated. The predictive values are used to measure how often 
a drug is correctly detected (or not detected) among the positive (or negative) results. 
Expressed as percentages, the sensitivity of the PS-MS/MS screen was 92.0% while the 
specificity was 99.8%. 89.0% of all positive PS hits were drugs which were genuinely 
present in the samples, and 99.8% of all undetected drugs were confirmed to be absent in 
the samples. 
 The quantitative results of those drugs which were detected by both methods are 
shown plotted against each other—HPLC on the x-axis and PS on the y-axis—in Figure 
26. In two methods with instrument responses that are directly proportional to changing 
concentrations, the slope of the regression line would be close to 1 and the calculated 
concentrations would directly correlate (the dashed line). However, in comparing PS-
MS/MS and HPLC-MS, the former tended to overestimate the actual concentration; at 95% 
confidence, the slope of the regression lay between 1.05-1.30, indicating that PS-
determined concentrations were biased high compared to HPLC. On average, the 
calculated concentrations based on the PS method were 58% different from the HPLC-
determined concentrations. Important to note, though, is the fact that the PS method was 
developed solely as a screening method, whereas the HPLC method was a comprehensive 
assay meant for quantitative and confirmatory testing. Despite this, the concentrations 
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determined by PS-MS/MS still correlated well with those determined by HPLC-MS, 
generating a Pearson correlation coefficient of 0.996. This indicates the utility of PS-
MS/MS in not only qualitative screening but also semi-quantitative analyses. 
 
Figure 26. Comparison of concentrations for the drugs detected and quantitated from the PM samples by 
both HPLC- and PS-based screening methods. The dashed line represents two methods whose quantitative 
performances are identical. 
Future Work 
 All analyses presented here relied solely on the detection of a single fragment ion 
in MS/MS mode. In most cases, the drugs fragmented into more than one ion when 
undergoing CID, but for purposes of maximizing method sensitivity, only the most 
abundant fragment ion was used for quantitation. To increase the specificity of this drug 
screen, one or more of these additional fragment ions could be included in the processing 
method to further streamline and automate analyses, which would allow the method to 
provide more reliable drug identifications without as much of a risk of false positives.129 
 Bearing in mind the work presented in Chapter 2, this positive ion drug screen could 
also be combined with a negative ion drug screen to create a much more comprehensive 
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technique for rapidly obtaining toxicologically relevant information. Currently, due to the 
differences in spray solvent needs between the two modes of ionization, they would have 
to be run separately, which is not ideal and would require running and processing unknown 
samples at least twice. However, if a universal solvent could be used for both polarities 
along with a unified sample preparation method that works for a wide variety of biological 
matrices, both acidic and basic drugs could be scanned for and processed simultaneously. 
Such a technique would be able to provide probative quantitation for 154 individual drugs 
in the span of three to four minutes, which would be an invaluable tool in an investigator’s 
arsenal. 
Conclusion 
 A PS-MS/MS drug screen was applied to the analysis of PM blood samples. 
Adjusting the spray solvent to 85:10:5:0.01 acetonitrile:acetone:water:acetic acid as well 
as mixing the samples with a larger volume of aqueous ISTD solution both proved to be 
critical modifications to the method to eliminate relative matrix effects. These adjustments 
were shown to lessen the ion suppression experienced by the ISTDs, producing more 
uniform signals across the calibrants and the 30 unknown PM samples than was previously 
achievable by the original method. Calibration curves were generated—establishing LORs 
and good linearity for almost all 137 analytes—and several drugs were able to be identified 
and quantitated from the PM samples. 
 The results from the PS-based drug screen were compared to those obtained 
independently via HPLC-MS. From the drugs which were identified and quantitated by 
both methods, concentrations determined by PS tended to slightly overestimate the true 
values; however, they showed a good overall correlation (R2 = 0.9924) with their 
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corresponding HPLC concentrations, indicating the semi-quantitative capabilities of PS-
MS/MS on top of its intended purposes for screening. Furthermore, the rates of false 
positives and negatives were worked out, and their effects on the diagnostic reliability of 
the technique were investigated. Because the scale of the screen was so large and most 
drugs screened for were absent from the samples, the number of negative results indicated 
an almost perfect NPV and specificity for PS. A much smaller number by comparison, the 
positive results led to a qualitative sensitivity of 92.0% and a PPV of 89.0%. Despite these 
disparities, though, these are still promising results that demonstrate the capability of PS-
MS/MS in screening for drugs on a level that rivals HPLC-MS, accomplishing the same 
task in a significantly simpler and quicker way. By comparing the newer technique to the 
older and more established technique of HPLC, PS-based drug screens further develop 
toward real-world application, where they could ultimately be used for rapid, effective, and 
cheap biomonitoring and toxicology.
95 
REFERENCES 
1. Gohlke, R. S.; McLafferty, F. W. Early gas chromatography/mass spectrometry. 
Journal of the American Society for Mass Spectrometry 1993, 4, 367-371. 
2. Hiraoka, K.; Kudaka, I. Electrospray interface for liquid chromatography/mass 
spectrometry. Rapid Communications in Mass Spectrometry 1990, 4, 519-526. 
3. Whitehouse, C. M.; Dreyer, R. N.; Yamashita, M.; Fenn, J. B. Electrospray 
interface for liquid chromatographs and mass spectrometers. Analytical Chemistry 
1985, 57, 675-679. 
4. Yamashita, M.; Fenn, J. B. Electrospray ion source. Another variation on the free-
jet theme. The Journal of Physical Chemistry 1984, 88, 4451-4459. 
5. Takáts, Z.; Wiseman, J. M.; Gologan, B.; Cooks, R. G. Mass spectrometry sampling 
under ambient conditions with desorption electrospray ionization. Science 2004, 
306, 471-473. 
6. Cody, R. B.; Laramée, J. A.; Durst, H. D. Versatile new ion source for the analysis 
of materials in open air under ambient conditions. Analytical Chemistry 2005, 77, 
2297-2302. 
7. Alberici, R. M.; Simas, R. C.; Sanvido, G. B.; Romão, W.; Lalli, P. M.; Benassi, 
M.; Cunha, I. B. S.; Eberlin, M. N. Ambient mass spectrometry: Bringing MS into 
the “real world”. Analytical and Bioanalytical Chemistry 2010, 398, 265-294. 
8. Tepper, G.; Kessick, R. Nanoelectrospray aerosols from microporous polymer wick 
sources. Applied Physics Letters 2009, 94, 084106. 
9. Liu, J.; Wang, H.; Manicke, N. E.; Lin, J.-M.; Cooks, R. G.; Ouyang, Z. 
Development, characterization, and application of paper spray ionization. 
Analytical Chemistry 2010, 82, 2463-2471. 
10. Manicke, N. E.; Abu-Rabie, P.; Spooner, N.; Ouyang, Z.; Cooks, R. G. Quantitative 
analysis of therapeutic drugs in dried blood spot samples by paper spray mass 
spectrometry: An avenue to therapeutic drug monitoring. Journal of the American 
Society for Mass Spectrometry 2011, 22, 1501-1507. 
11. Manicke, N. E.; Yang, Q.; Wang, H.; Oradu, S.; Ouyang, Z.; Cooks, R. G. 
Assessment of paper spray ionization for quantitation of pharmaceuticals in blood 
spots. International Journal of Mass Spectrometry 2011, 300, 123-129. 
12. Wang, H.; Liu, J.; Cooks, R. G.; Ouyang, Z. Paper spray for direct analysis of 
complex mixtures using mass spectrometry. Angewandte Chemie 2010, 122, 889-
892. 
13. Wang, H.; Manicke, N. E.; Yang, Q.; Zheng, L.; Shi, R.; Cooks, R. G.; Ouyang, Z. 
Direct analysis of biological tissue by paper spray mass spectrometry. Analytical 
Chemistry 2011, 83, 1197-1201. 
96 
14. Zhang, Z.; Xu, W.; Manicke, N. E.; Cooks, R. G.; Ouyang, Z. Silica coated paper 
substrate for paper-spray analysis of therapeutic drugs in dried blood spots. 
Analytical Chemistry 2012, 84, 931-938. 
15. Narayanan, R.; Sarkar, D.; Cooks, R. G.; Pradeep, T. Molecular ionization from 
carbon nanotube paper. Angewandte Chemie International Edition 2014, 53, 5936-
5940. 
16. Wong, M. Y.-M.; Man, S.-H.; Che, C.-M.; Lau, K.-C.; Ng, K.-M. Negative 
electrospray ionization on porous supporting tips for mass spectrometric analysis: 
Electrostatic charging effect on detection sensitivity and its application to explosive 
detection. Analyst 2014, 139, 1482-1491. 
17. Wong, M. Y.-M.; Tang, H.-W.; Man, S.-H.; Lam, C.-W.; Che, C.-M.; Ng, K.-M. 
Electrospray ionization on porous spraying tips for direct sample analysis by mass 
spectrometry: Enhanced detection sensitivity and selectivity using 
hydrophobic/hydrophilic materials as spraying tips. Rapid Communications in 
Mass Spectrometry 2013, 27, 713-721. 
18. Hu, B.; So, P.-K.; Chen, H.; Yao, Z.-P. Electrospray ionization using wooden tips. 
Analytical Chemistry 2011, 83, 8201-8207. 
19. Liu, J.; Wang, H.; Cooks, R. G.; Ouyang, Z. Leaf spray: Direct chemical analysis 
of plant material and living plants by mass spectrometry. Analytical Chemistry 
2011, 83, 7608-7613. 
20. Li, M.; Zhang, J.; Jiang, J.; Zhang, J.; Gao, J.; Qiao, X. Rapid, in situ detection of 
cocaine residues based on paper spray ionization coupled with ion mobility 
spectrometry. Analyst 2014, 139, 1687-1691. 
21. Soparawalla, S.; Tadjimukhamedov, F. K.; Wiley, J. S.; Ouyang, Z.; Cooks, R. G. 
In situ analysis of agrochemical residues on fruit using ambient ionization on a 
handheld mass spectrometer. Analyst 2011, 136, 4392-4396. 
22. Li, L.; Chen, T.-C.; Ren, Y.; Hendricks, P. I.; Cooks, R. G.; Ouyang, Z. Mini 12, 
miniature mass spectrometer for clinical and other applications—introduction and 
characterization. Analytical Chemistry 2014, 86, 2909-2916. 
23. Snyder, D. T.; Pulliam, C. J.; Ouyang, Z.; Cooks, R. G. Miniature and fieldable 
mass spectrometers: Recent advances. Analytical Chemistry 2016, 88, 2-29. 
24. Espy, R. D.; Teunissen, S. F.; Manicke, N. E.; Ren, Y.; Ouyang, Z.; van Asten, A.; 
Cooks, R. G. Paper spray and extraction spray mass spectrometry for the direct and 
simultaneous quantification of eight drugs of abuse in whole blood. Analytical 
Chemistry 2014, 86, 7712-7718. 
25. Su, Y.; Wang, H.; Liu, J.; Wei, P.; Cooks, R. G.; Ouyang, Z. Quantitative paper 
spray mass spectrometry analysis of drugs of abuse. Analyst 2013, 138, 4443-4447. 
26. Wang, H.; Ren, Y.; McLuckey, M. N.; Manicke, N. E.; Park, J.; Zheng, L.; Shi, R.; 
Cooks, R. G.; Ouyang, Z. Direct quantitative analysis of nicotine alkaloids from 
biofluid samples using paper spray mass spectrometry. Analytical Chemistry 2013, 
85, 11540-11544. 
97 
27. Salentijn, G. I. J.; Permentier, H. P.; Verpoorte, E. 3D-printed paper spray 
ionization cartridge with fast wetting and continuous solvent supply features. 
Analytical Chemistry 2014, 86, 11657-11665. 
28. Zhang, Z.; Cooks, R. G.; Ouyang, Z. Paper spray: A simple and efficient means of 
analysis of different contaminants in foodstuffs. Analyst 2012, 137, 2556-2558. 
29. Zhang, Y.; Li, H.; Ma, Y.; Lin, J.-M. Paper spray mass spectrometry-based method 
for analysis of droplets in a gravity-driven microfluidic chip. Analyst 2014, 139, 
1023-1029. 
30. Yang, Q.; Manicke, N. E.; Wang, H.; Petucci, C.; Cooks, R. G.; Ouyang, Z. Direct 
and quantitative analysis of underivatized acylcarnitines in serum and whole blood 
using paper spray mass spectrometry. Analytical and Bioanalytical Chemistry 
2012, 404, 1389-1397. 
31. Amador, V. S.; Pereira, H. V.; Sena, M. M.; Augusti, R.; Piccin, E. Paper spray 
mass spectrometry for the forensic analysis of black ballpoint pen inks. Journal of 
the American Society for Mass Spectrometry 2017, 1-12. 
32. da Silva Ferreira, P.; Fernandes de Abreu e Silva, D.; Augusti, R.; Piccin, E. 
Forensic analysis of ballpoint pen inks using paper spray mass spectrometry. 
Analyst 2015, 140, 811-819. 
33. Jett, R. (2017). Paper spray mass spectrometry for rapid drug screening (Master's 
thesis). Purdue University (Indianapolis, IN). 
34. Jett, R.; Skaggs, C.; Manicke, N. Drug screening method development for paper 
spray coupled to a triple quadrupole mass spectrometer. Analytical Methods 2017. 
35. Espy, R. D.; Muliadi, A. R.; Ouyang, Z.; Cooks, R. G. Spray mechanism in paper 
spray ionization. International Journal of Mass Spectrometry 2012, 325–327, 167-
171. 
36. Ikonomou, M. G.; Blades, A. T.; Kebarle, P. Electrospray mass spectrometry of 
methanol and water solutions suppression of electric discharge with SF6 gas. 
Journal of the American Society for Mass Spectrometry 1991, 2, 497-505. 
37. Goldman, M.; Goldman, A., in Gaseous Electronics, Volume I: Electrical 
Discharges, Hirsh, M. N.; Oskam, H. J., Eds. (Academic Press, New York, NY, 
1978), 219-290. 
38. Raizer, Y. P., in Gas Discharge Physics, Allen, J. E., Ed. (Springer-Verlag, Berlin, 
1991), 324-377. 
39. Skalny, J. D.; Mikoviny, T.; Matejcik, S.; Mason, N. J. An analysis of mass 
spectrometric study of negative ions extracted from negative corona discharge in 
air. International Journal of Mass Spectrometry 2004, 233, 317-324. 
40. Faircloth, D. C. Technological aspects: High voltage. CERN Yellow Report 2013, 
2013, 381-419. 
41. Loeb, L. B. Electrical Coronas: Their Basic Physical Mechanisms.  (University of 
California Press, Berkeley, CA, 1965). 
98 
42. Busch, K. Space charge in mass spectrometry. Spectroscopy 2004, 19, 35-38. 
43. Wampler, F. M.; Blades, A. T.; Kebarle, P. Negative ion electrospray mass 
spectrometry of nucleotides: Ionization from water solution with SF6 discharge 
suppression. Journal of the American Society for Mass Spectrometry 1993, 4, 289-
295. 
44. Yamashita, M.; Fenn, J. B. Negative ion production with the electrospray ion 
source. The Journal of Physical Chemistry 1984, 88, 4671-4675. 
45. Cole, R. B.; Harrata, A. K. Charge-state distribution and electric-discharge 
suppression in negative-ion electrospray mass spectrometry using chlorinated 
solvents. Rapid Communications in Mass Spectrometry 1992, 6, 536-539. 
46. Hiraoka, K.; Kudaka, I. Negative-mode electrospray-mass spectrometry using 
nonaqueous solvents. Rapid Communications in Mass Spectrometry 1992, 6, 265-
268. 
47. Cech, N. B.; Enke, C. G. Practical implications of some recent studies in 
electrospray ionization fundamentals. Mass Spectrometry Reviews 2001, 20, 362-
387. 
48. Jackson, G. S.; Enke, C. G. Electrical equivalence of electrospray ionization with 
conducting and nonconducting needles. Analytical Chemistry 1999, 71, 3777-3784. 
49. Jaworek, A.; Sobczyk, A.; Czech, T.; Krupa, A. Corona discharge in 
electrospraying. Journal of Electrostatics 2014, 72, 166-178. 
50. López-Muñoz, F.; Ucha-Udabe, R.; Alamo, C. The history of barbiturates a century 
after their clinical introduction. Neuropsychiatric Disease and Treatment 2005, 1, 
329-343. 
51. Ikonomou, M. G.; Blades, A. T.; Kebarle, P. Investigations of the electrospray 
interface for liquid chromatography/mass spectrometry. Analytical Chemistry 
1990, 62, 957-967. 
52. Diaz, A. F.; Felix-Navarro, R. M. A semi-quantitative tribo-electric series for 
polymeric materials: The influence of chemical structure and properties. Journal of 
Electrostatics 2004, 62, 277-290. 
53. Wleklinski, M.; Li, Y.; Bag, S.; Sarkar, D.; Narayanan, R.; Pradeep, T.; Cooks, R. 
G. Zero volt paper spray ionization and its mechanism. Analytical Chemistry 2015, 
87, 6786-6793. 
54. Smith, D. P. H. The electrohydrodynamic atomization of liquids. IEEE 
Transactions on Industry Applications 1986, IA-22, 527-535. 
55. Conference of Plenipotentiaries on the Protocol on Chlorofluorocarbons to the 
Vienna Convention for the Protection of the Ozone Layer. Amendment to the 
Montreal Protocol on substances that deplete the ozone layer 1990. United Nations 
(London, United Kingdom). 
56. Hamilton, A. Formation of phosgene in thermal decomposition of carbon 
tetrachloride. Industrial & Engineering Chemistry 1933, 25, 539-541. 
99 
57. Kubic, V. L.; Anders, M. W. Metabolism of carbon tetrachloride to phosgene. Life 
Sciences 1980, 26, 2151-2155. 
58. International Agency for Research on Cancer. List of classifications 2017. United 
Nations (Lyon, France). 
59. Compton, R. N.; Cooper, C. D. Negative ion properties of 
tetracyanoquinodimethan: Electron affinity and compound states. The Journal of 
Chemical Physics 1977, 66, 4325-4329. 
60. Staneke, P. O.; Groothuis, G.; Ingemann, S.; Nibbering, N. M. M. Formation, 
stability and structure of radical anions of chloroform, tetrachloromethane and 
fluorotrichloromethane in the gas phase. International Journal of Mass 
Spectrometry and Ion Processes 1995, 142, 83-93. 
61. McKenna, J.; Dhummakupt, E. S.; Connell, T.; Demond, P. S.; Miller, D. B.; Nilles, 
J. M.; Manicke, N. E.; Glaros, T. Detection of chemical warfare agent simulants 
and hydrolysis products in biological samples by paper spray mass spectrometry. 
Analyst 2017, 142, 1442-1451. 
62. Benschop, H. P.; van der Schans, G. P.; Noort, D.; Fidder, A.; Mars-Groenendijk, 
R. H.; de Jong, L. P. A. Verification of exposure to sulfur mustard in two casualties 
of the Iran-Iraq conflict. Journal of Analytical Toxicology 1997, 21, 249-251. 
63. Black, R. M.; Clarke, R. J.; Read, R. W.; Reid, M. T. J. Application of gas 
chromatography-mass spectrometry and gas chromatography-tandem mass 
spectrometry to the analysis of chemical warfare samples, found to contain residues 
of the nerve agent sarin, sulphur mustard and their degradation products. Journal 
of Chromatography A 1994, 662, 301-321. 
64. Organisation for the Prohibition of Chemical Weapons. Convention on the 
prohibition of the development, production, stockpiling and use of chemical 
weapons and on their destruction 1993. United Nations (New York, NY). 
65. Matsuda, Y.; Nagao, M.; Takatori, T.; Niijima, H.; Nakajima, M.; Iwase, H.; 
Kobayashi, M.; Iwadate, K. Detection of the sarin hydrolysis product in formalin-
fixed brain tissues of victims of the Tokyo subway terrorist attack. Toxicology and 
Applied Pharmacology 1998, 150, 310-320. 
66. Nagao, M.; Takatori, T.; Matsuda, Y.; Nakajima, M.; Iwase, H.; Iwadate, K. 
Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. 
Toxicology and Applied Pharmacology 1997, 144, 198-203. 
67. Noort, D.; Hulst, A. G.; Platenburg, D. H. J. M.; Polhuijs, M.; Benschop, H. P. 
Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of 
Japanese citizens allegedly exposed to sarin: Estimation of internal dosage. 
Archives of Toxicology 1998, 72, 671-675. 
68. Tu, A. T. Aum Shinrikyo’s chemical and biological weapons: More than sarin. 
Forensic Science Review 2014, 26, 115-120. 
69. Berlinger, J. VX nerve agent used to kill Kim Jong Nam, police say. CNN 2017. 
http://www.cnn.com/2017/02/23/asia/kim-jong-nam-vx-nerve-agent/. 
100 
70. Dewan, A.; Alkashali, H. Syria chemical attack: Authority finds 'incontrovertible' 
evidence of sarin. CNN 2017. http://www.cnn.com/2017/04/20/middleeast/syria-
chemical-attack-sarin-opcw/. 
71. Hakeem, O.; Jabri, S. Adverse birth outcomes in women exposed to Syrian 
chemical attack. The Lancet Global Health 2015, 3, e196. 
72. Pita, R.; Domingo, J. The use of chemical weapons in the Syrian conflict. Toxics 
2014, 2, 391-402. 
73. Rosman, Y.; Eisenkraft, A.; Milk, N.; Shiyovich, A.; Ophir, N.; Shrot, S.; Kreiss, 
Y.; Kassirer, M. Lessons learned from the Syrian sarin attack: Evaluation of a 
clinical syndrome through social media. Annals of Internal Medicine 2014, 160, 
644-648. 
74. Bajgar, J. Organophosphates/nerve agent poisoning: Mechanism of action, 
diagnosis, prophylaxis, and treatment. Advances in Clinical Chemistry 2004, 38, 
151-216. 
75. Ganesan, K.; Raza, S.; Vijayaraghavan, R. Chemical warfare agents. Journal of 
Pharmacy And Bioallied Sciences 2010, 2, 166-178. 
76. Munro, N. B.; Talmage, S. S.; Griffin, G. D.; Waters, L. C.; Watson, A. P.; King, 
J. F.; Hauschild, V. The sources, fate, and toxicity of chemical warfare agent 
degradation products. Environmental Health Perspectives 1999, 107, 933-974. 
77. Cannard, K. The acute treatment of nerve agent exposure. Journal of the 
Neurological Sciences 2006, 249, 86-94. 
78. Noeller, T. P. Biological and chemical terrorism: Recognition and management. 
Cleveland Clinic Journal of Medicine 2001, 68, 1001-1016. 
79. Murray, V.; Goodfellow, F. Mass casualty chemical incidents—towards guidance 
for public health management. Public Health 2002, 116, 2-14. 
80. D’Agostino, P. A.; Hancock, J. R.; Provost, L. R. Determination of sarin, soman 
and their hydrolysis products in soil by packed capillary liquid chromatography–
electrospray mass spectrometry. Journal of Chromatography A 2001, 912, 291-
299. 
81. John, H.; Worek, F.; Thiermann, H. LC-MS-based procedures for monitoring of 
toxic organophosphorus compounds and verification of pesticide and nerve agent 
poisoning. Analytical & Bioanalytical Chemistry 2008, 391, 97-116. 
82. Lakso, H.-Å.; Ng, W. F. Determination of chemical warfare agents in natural water 
samples by solid-phase microextraction. Analytical Chemistry 1997, 69, 1866-
1872. 
83. Ketkar, S. N.; Dulak, J. G.; Fite, W. L.; Buchner, J. D.; Dheandhanoo, S. 
Atmospheric pressure ionization tandem mass spectrometric system for real-time 
detection of low-level pollutants in air. Analytical Chemistry 1989, 61, 260-264. 
 
101 
84. Seto, Y.; Kanamori-Kataoka, M.; Tsuge, K.; Ohsawa, I.; Iura, K.; Itoi, T.; 
Sekiguchi, H.; Matsushita, K.; Yamashiro, S.; Sano, Y.; Sekiguchi, H.; Maruko, H.; 
Takayama, Y.; Sekioka, R.; Okumura, A.; Takada, Y.; Nagano, H.; Waki, I.; 
Ezawa, N.; Tanimoto, H.; Honjo, S.; Fukano, M.; Okada, H. Sensitive monitoring 
of volatile chemical warfare agents in air by atmospheric pressure chemical 
ionization mass spectrometry with counter-flow introduction. Analytical Chemistry 
2013, 85, 2659-2666. 
85. Nilles, J. M.; Connell, T. R.; Durst, H. D. Quantitation of chemical warfare agents 
using the direct analysis in real time (DART) technique. Analytical Chemistry 2009, 
81, 6744-6749. 
86. D’Agostino, P. A.; Hancock, J. R.; Chenier, C. L.; Lepage, C. R. J. Liquid 
chromatography electrospray tandem mass spectrometric and desorption 
electrospray ionization tandem mass spectrometric analysis of chemical warfare 
agents in office media typically collected during a forensic investigation. Journal 
of Chromatography A 2006, 1110, 86-94. 
87. D'Agostino, P. A.; Chenier, C. L.; Hancock, J. R.; Lepage, C. R. J. Desorption 
electrospray ionisation mass spectrometric analysis of chemical warfare agents 
from solid-phase microextraction fibers. Rapid Communications in Mass 
Spectrometry 2007, 21, 543-549. 
88. Reeber, S. L.; Gadi, S.; Huang, S.-B.; Glish, G. L. Direct analysis of herbicides by 
paper spray ionization mass spectrometry. Analytical Methods 2015, 7, 9808-9816. 
89. Black, R. M.; Muir, B. Derivatisation reactions in the chromatographic analysis of 
chemical warfare agents and their degradation products. Journal of 
Chromatography A 2003, 1000, 253-281. 
90. Sng, M. T.; Ng, W. F. In-situ derivatisation of degradation products of chemical 
warfare agents in water by solid-phase microextraction and gas chromatographic–
mass spectrometric analysis. Journal of Chromatography A 1999, 832, 173-182. 
91. Rohrbaugh, D. K.; Sarver, E. W. Detection of alkyl methylphosphonic acids in 
complex matrices by gas chromatography–tandem mass spectrometry. Journal of 
Chromatography A 1998, 809, 141-150. 
92. Black, R. M.; Read, R. W. Application of liquid chromatography-atmospheric 
pressure chemical ionisation mass spectrometry, and tandem mass spectrometry, to 
the analysis and identification of degradation products of chemical warfare agents. 
Journal of Chromatography A 1997, 759, 79-92. 
93. Liu, Q.; Hu, X.; Xie, J. Determination of nerve agent degradation products in 
environmental samples by liquid chromatography–time-of-flight mass 
spectrometry with electrospray ionization. Analytica Chimica Acta 2004, 512, 93-
101. 
94. Owens, J.; Vu, A.; Koester, C. Analysis of phosphonic acids: Validation of semi-
volatile analysis by HPLC-MS/MS by EPA method MS999. Lawrence Livermore 
National Laboratory 2008. https://e-reports-ext.llnl.gov/pdf/367241.pdf. 
102 
95. Read, R. W.; Black, R. M. Rapid screening procedures for the hydrolysis products 
of chemical warfare agents using positive and negative ion liquid chromatography–
mass spectrometry with atmospheric pressure chemical ionisation. Journal of 
Chromatography A 1999, 862, 169-177. 
96. Black, R. M.; Read, R. W. Analysis of degradation products of organophosphorus 
chemical warfare agents and related compounds by liquid chromatography–mass 
spectrometry using electrospray and atmospheric pressure chemical ionisation. 
Journal of Chromatography A 1998, 794, 233-244. 
97. Song, Y.; Cooks, R. G. Reactive desorption electrospray ionization for selective 
detection of the hydrolysis products of phosphonate esters. Journal of Mass 
Spectrometry 2007, 42, 1086-1092. 
98. Kingdon, K. H. A method for the neutralization of electron space charge by positive 
ionization at very low gas pressures. Physical Review 1923, 21, 408-418. 
99. Hu, Q.; Noll, R. J.; Li, H.; Makarov, A.; Hardman, M.; Cooks, R. G. The Orbitrap: 
A new mass spectrometer. Journal of Mass Spectrometry 2005, 40, 430-443. 
100. Makarov, A. Electrostatic axially harmonic orbital trapping:  A high-performance 
technique of mass analysis. Analytical Chemistry 2000, 72, 1156-1162. 
101. Comisarow, M. B.; Marshall, A. G. Fourier transform ion cyclotron resonance 
spectroscopy. Chemical Physics Letters 1974, 25, 282-283. 
102. Comisarow, M. B.; Marshall, A. G. Frequency-sweep Fourier transform ion 
cyclotron resonance spectroscopy. Chemical Physics Letters 1974, 26, 489-490. 
103. Cotter, R. J. Peer reviewed: The new time-of-flight mass spectrometry. Analytical 
Chemistry 1999, 71, 445A-451A. 
104. Wong, P. S. H.; Cooks, R. G. Ion trap mass spectrometry. Current Separations 
1997, 16, 85-92. 
105. Soni, M.; Frankevich, V.; Nappi, M.; Santini, R. E.; Amy, J. W.; Cooks, R. G. 
Broad-band Fourier transform quadrupole ion trap mass spectrometry. Analytical 
Chemistry 1996, 68, 3314-3320. 
106. Marshall, A. G.; Hendrickson, C. L.; Jackson, G. S. Fourier transform ion cyclotron 
resonance mass spectrometry: A primer. Mass Spectrometry Reviews 1998, 17, 1-
35. 
107. Mamyrin, B. A.; Karataev, V. I.; Shmikk, D. V.; Zagulin, V. A. The mass-
reflectron, a new nonmagnetic time-of-flight mass spectrometer with high 
resolution. Journal of Experimental and Theoretical Physics 1973, 37, 45-48. 
108. Toyoda, M.; Okumura, D.; Ishihara, M.; Katakuse, I. Multi-turn time-of-flight mass 
spectrometers with electrostatic sectors. Journal of Mass Spectrometry 2003, 38, 
1125-1142. 
109. Yavor, M.; Verentchikov, A.; Hasin, J.; Kozlov, B.; Gavrik, M.; Trufanov, A. 
Planar multi-reflecting time-of-flight mass analyzer with a jig-saw ion path. 
Physics Procedia 2008, 1, 391-400. 
103 
110. Dawson, J. H. J.; Guilhaus, M. Orthogonal-acceleration time-of-flight mass 
spectrometer. Rapid Communications in Mass Spectrometry 1989, 3, 155-159. 
111. Verentchikov, A. N.; Ens, W.; Standing, K. G. Reflecting time-of-flight mass 
spectrometer with an electrospray ion source and orthogonal extraction. Analytical 
Chemistry 1994, 66, 126-133. 
112. Krauss, M.; Singer, H.; Hollender, J. LC–high resolution MS in environmental 
analysis: From target screening to the identification of unknowns. Analytical and 
Bioanalytical Chemistry 2010, 397, 943-951. 
113. Rajski, Ł.; Gómez-Ramos, M. d. M.; Fernández-Alba, A. R. Large pesticide 
multiresidue screening method by liquid chromatography-Orbitrap mass 
spectrometry in full scan mode applied to fruit and vegetables. Journal of 
Chromatography A 2014, 1360, 119-127. 
114. Savory, J. J.; Kaiser, N. K.; McKenna, A. M.; Xian, F.; Blakney, G. T.; Rodgers, 
R. P.; Hendrickson, C. L.; Marshall, A. G. Parts-per-billion Fourier transform ion 
cyclotron resonance mass measurement accuracy with a “walking” calibration 
equation. Analytical Chemistry 2011, 83, 1732-1736. 
115. Shi, S. D. H.; Hendrickson, C. L.; Marshall, A. G. Counting individual sulfur atoms 
in a protein by ultrahighresolution Fourier transform ion cyclotron resonance mass 
spectrometry: Experimental resolution of isotopic fine structure in proteins. 
Proceedings of the National Academy of Sciences 1998, 95, 11532-11537. 
116. Marshall, A. G.; Hendrickson, C. L. High-resolution mass spectrometers. Annual 
Review of Analytical Chemistry 2008, 1, 579-599. 
117. Bateman, K. P.; Kellmann, M.; Muenster, H.; Papp, R.; Taylor, L. Quantitative–
qualitative data acquisition using a benchtop orbitrap mass spectrometer. Journal 
of the American Society for Mass Spectrometry 2009, 20, 1441-1450. 
118. Gómez-Ramos, M. M.; Ferrer, C.; Malato, O.; Agüera, A.; Fernández-Alba, A. R. 
Liquid chromatography-high-resolution mass spectrometry for pesticide residue 
analysis in fruit and vegetables: Screening and quantitative studies. Journal of 
Chromatography A 2013, 1287, 24-37. 
119. Zhang, N. R.; Yu, S.; Tiller, P.; Yeh, S.; Mahan, E.; Emary, W. B. Quantitation of 
small molecules using high-resolution accurate mass spectrometers – a different 
approach for analysis of biological samples. Rapid Communications in Mass 
Spectrometry 2009, 23, 1085-1094. 
120. Hogenboom, A. C.; van Leerdam, J. A.; de Voogt, P. Accurate mass screening and 
identification of emerging contaminants in environmental samples by liquid 
chromatography–hybrid linear ion trap Orbitrap mass spectrometry. Journal of 
Chromatography A 2009, 1216, 510-519. 
121. Lim, H.-K.; Chen, J.; Sensenhauser, C.; Cook, K.; Subrahmanyam, V. Metabolite 
identification by data-dependent accurate mass spectrometric analysis at resolving 
power of 60000 in external calibration mode using an LTQ/Orbitrap. Rapid 
Communications in Mass Spectrometry 2007, 21, 1821-1832. 
104 
122. Alder, L.; Steinborn, A.; Bergelt, S. Suitability of an orbitrap mass spectrometer for 
the screening of pesticide residues in extracts of fruits and vegetables. Journal of 
AOAC International 2011, 94, 1661-1673. 
123. Kolmonen, M.; Leinonen, A.; Pelander, A.; Ojanperä, I. A general screening 
method for doping agents in human urine by solid phase extraction and liquid 
chromatography/time-of-flight mass spectrometry. Analytica Chimica Acta 2007, 
585, 94-102. 
124. Hardman, M.; Makarov, A. A. Interfacing the orbitrap mass analyzer to an 
electrospray ion source. Analytical Chemistry 2003, 75, 1699-1705. 
125. Olsen, J. V.; de Godoy, L. M. F.; Li, G.; Macek, B.; Mortensen, P.; Pesch, R.; 
Makarov, A.; Lange, O.; Horning, S.; Mann, M. Parts per million mass accuracy 
on an orbitrap mass spectrometer via lock mass injection into a C-trap. Molecular 
& Cellular Proteomics 2005, 4, 2010-2021. 
126. Kaufmann, A.; Dvorak, V.; Crüzer, C.; Butcher, P.; Maden, K.; Walker, S.; 
Widmer, M.; Schürmann, A. Study of high-resolution mass spectrometry 
technology as a replacement for tandem mass spectrometry in the field of 
quantitative pesticide residue analysis. Journal of AOAC International 2012, 95, 
528-548. 
127. Vega, C.; Spence, C.; Zhang, C.; Bills, B. J.; Manicke, N. E. Ionization suppression 
and recovery in direct biofluid analysis using paper spray mass spectrometry. 
Journal of the American Society for Mass Spectrometry 2016, 27, 726-734. 
128. Akobeng, A. K. Understanding diagnostic tests 1: Sensitivity, specificity and 
predictive values. Acta Pædiatrica 2007, 96, 338-341. 
129. Pozo, Ó. J.; Sancho, J. V.; Ibáñez, M.; Hernández, F.; Niessen, W. M. A. 
Confirmation of organic micropollutants detected in environmental samples by 
liquid chromatography tandem mass spectrometry: Achievements and pitfalls. 
Trends in Analytical Chemistry 2006, 25, 1030-1042. 
105 
VITA 
 Josiah McKenna graduated from D.C. Everest High School (Weston, WI) as a 
valedictorian in 2011. He went on to pursue a B.S. in Chemistry as well as minors in 
Theatre Arts and English from Carroll University (Waukesha, WI). In summer 2014, he 
was awarded the Thronson Fellowship, which gave him the opportunity to do research 
under Dr. John Parkinson at the University of Strathclyde (Glasgow, Scotland), focusing 
on method development for nuclear magnetic resonance spectroscopy. After graduating 
summa cum laude from Carroll University in 2015, he began graduate school at Indiana 
University – Purdue University Indianapolis (Indianapolis, IN), performing research in 
mass spectrometry under Dr. Nick Manicke. In 2017, he obtained his M.S. in Forensic 
Science. 
